Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q
☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission file number: 000-54685


CNL Healthcare Properties, Inc. (Exact name of registrant as specified in its charter)


Maryland						27-2876363
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)
CNL Center at City Commons 450 South Orange Avenue Orlando, Florida						32801
(Address of principal executive offices)						(Zip Code)
Registrant’s telephone number, including area code (407) 650-1000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

The number of shares of common stock of the registrant outstanding as of November 7, 2024 was 175,274,045.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

INDEX


		Page
PART I. FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Information (unaudited):
	Condensed Consolidated Balance Sheets	2
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Income (Loss)	4
	Condensed Consolidated Statements of Stockholders’ Equity	5
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.	Quantitative and Qualitative Disclosures about Market Risks	28
Item 4.	Controls and Procedures	28

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	29
Item 1A.	Risk Factors	29
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 3.	Defaults Upon Senior Securities	29
Item 4.	Mine Safety Disclosures	29
Item 5.	Other Information	29
Item 6.	Exhibits	29

Exhibit Index		30
Signatures		31
Exhibits

PART I. FINANCIAL INFORMATION

Item 1.Condensed Consolidated Financial Information

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in thousands, except per share data)


ASSETS	September 30, 2024		December 31, 2023
Real estate investment properties, net (including one VIE $29,986 and $30,041, respectively)	$	1,252,461	$	1,279,137

Cash (including one VIE $1,819 and $1,515, respectively)	50,516		54,097
Restricted cash (including one VIE $459 and $8, respectively)	3,045		1,791
Other assets (including one VIE $142 and $246, respectively)	18,918		19,127
Deferred rent, lease incentives and intangibles, net	10,366		11,386
Total assets	$	1,335,306	$	1,365,538
LIABILITIES AND EQUITY
Liabilities:
Mortgages and other notes payable, net (including one VIE $20,219 and $20,622, respectively)	$	36,017	$	36,569
Credit facilities, net	533,752		541,840
Accounts payable and accrued liabilities (including one VIE $1,439 and $1,411, respectively)	32,073		31,322
Other liabilities (including one VIE $318 and $216, respectively)	12,695		10,475
Due to related parties	177		1,292
Total liabilities	614,714		621,498
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding	―		—
Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding	―		—
Common stock, $0.01 par value per share, 1,120,000 shares authorized, 187,958 shares issued and 175,274 shares outstanding	1,739		1,739
Capital in excess of par value	1,516,806		1,516,806
Accumulated income	65,199		74,710
Accumulated distributions	(860,479)		(847,120)
Accumulated other comprehensive loss	(3,193)		(2,572)
Total stockholders' equity	720,072		743,563
Noncontrolling interest	520		477
Total equity	720,592		744,040
Total liabilities and equity	$	1,335,306	$	1,365,538

The abbreviation VIEs above means variable interest entities.

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(in thousands, except per share data)


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Revenues:
Rental income and related revenues	$	6,920	$	6,730	$	20,539	$	20,166
Resident fees and services	85,877		79,483		252,223		234,892
Total revenues	92,797		86,213		272,762		255,058
Operating expenses:
Property operating expenses	62,582		59,395		181,772		175,687
General and administrative expenses	1,841		2,015		6,251		6,569
Asset management fees	3,337		3,476		10,011		10,427
Property management fees	4,277		3,881		12,429		11,543
Financing coordination fees	—		—		—		163
Depreciation and amortization	12,619		12,471		37,785		38,741
Total operating expenses	84,656		81,238		248,248		243,130

Operating income	8,141		4,975		24,514		11,928
Other income (expense):
Interest and other income	356		506		945		2,510
Interest expense and loan cost amortization	(11,527)		(10,762)		(34,564)		(30,680)


Total other expense	(11,171)		(10,256)		(33,619)		(28,170)
Loss before income taxes	(3,030)		(5,281)		(9,105)		(16,242)
Income tax expense	(125)		(118)		(363)		(321)


Net loss	(3,155)		(5,399)		(9,468)		(16,563)

Less: Amounts attributable to noncontrolling interests	19		15		43		17
Net loss attributable to common stockholders	$	(3,174)	$	(5,414)	$	(9,511)	$	(16,580)


Net loss per share of common stock (basic and diluted)	$	(0.02)	$	(0.03)	$	(0.05)	$	(0.10)

Weighted average number of shares of common stock outstanding (basic and diluted)	173,942		173,960		173,942		173,960

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

(in thousands)


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net loss	$	(3,155)	$	(5,399)	$	(9,468)	$	(16,563)
Other comprehensive (loss) income:
Unrealized (loss) gain on derivative financial instruments, net	(4,561)		56		(621)		7

Total other comprehensive (loss) income	(4,561)		56		(621)		7
Comprehensive loss	(7,716)		(5,343)		(10,089)		(16,556)
Less: Comprehensive income attributable to noncontrolling interest	19		15		43		17
Comprehensive loss attributable to common stockholders	$	(7,735)	$	(5,358)	$	(10,132)	$	(16,573)

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

(in thousands, except per share data)


										Accumulated
	Common Stock			Capital in						Other		Total		Non-
	Number	Par		Excess of		Accumulated		Accumulated		Comprehensive		Stockholders'		controlling		Total
	of Shares	Value		Par Value		Income		Distributions		Income (Loss)		Equity		Interest		Equity
Balance at June 30, 2024	173,942	$	1,739	$	1,516,806	$	68,373	$	(856,026)	$	1,368	$	732,260	$	501	$	732,761
Net (loss) income	—	—		—		(3,174)		—		—		(3,174)		19		(3,155)
Other comprehensive loss	—	—		—		—		—		(4,561)		(4,561)		—		(4,561)

Cash distributions declared ($0.0256 per share)	—	—		—		—		(4,453)		—		(4,453)		—		(4,453)
Balance at September 30, 2024	173,942	$	1,739	$	1,516,806	$	65,199	$	(860,479)	$	(3,193)	$	720,072	$	520	$	720,592


										Accumulated
	Common Stock			Capital in						Other		Total		Non-
	Number	Par		Excess of		Accumulated		Accumulated		Comprehensive		Stockholders'		controlling		Total
	of Shares	Value		Par Value		Income		Distributions		Income (Loss)		Equity		Interest		Equity
Balance at December 31, 2023	173,942	$	1,739	$	1,516,806	$	74,710	$	(847,120)	$	(2,572)	$	743,563	$	477	$	744,040
Net (loss) income	—	—		—		(9,511)		—		—		(9,511)		43		(9,468)
Other comprehensive loss	—	—		—		—		—		(621)		(621)		—		(621)

Cash distributions declared ($0.0768 per share)	—	—		—		—		(13,359)		—		(13,359)		—		(13,359)
Balance at September 30, 2024	173,942	$	1,739	$	1,516,806	$	65,199	$	(860,479)	$	(3,193)	$	720,072	$	520	$	720,592

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2023 (UNAUDITED)

(in thousands, except per share data)


										Accumulated
	Common Stock			Capital in						Other		Total		Non-
	Number	Par		Excess of		Accumulated		Accumulated		Comprehensive		Stockholders'		controlling		Total
	of Shares	Value		Par Value		Income		Distributions		Income (Loss)		Equity		Interest		Equity
Balance at June 30, 2023	173,960	$	1,740	$	1,516,926	$	89,242	$	(838,213)	$	(65)	$	769,630	$	487	$	770,117
Net (loss) income	—	—		—		(5,414)		—		—		(5,414)		15		(5,399)
Other comprehensive income	—	—		—		—		—		56		56		—		56
Distributions to noncontrolling interests	—	—		—		—		—		—		—		(13)		(13)
Cash distributions declared ($0.0256 per share)	—	—		—		—		(4,454)		—		(4,454)		—		(4,454)
Balance at September 30, 2023	173,960	$	1,740	$	1,516,926	$	83,828	$	(842,667)	$	(9)	$	759,818	$	489	$	760,307


										Accumulated
	Common Stock			Capital in						Other		Total		Non-
	Number	Par		Excess of		Accumulated		Accumulated		Comprehensive		Stockholders'		controlling		Total
	of Shares	Value		Par Value		Income		Distributions		Income (Loss)		Equity		Interest		Equity
Balance at December 31, 2022	173,960	$	1,740	$	1,516,926	$	100,408	$	(829,307)	$	(16)	$	789,751	$	543	$	790,294
Net (loss) income	—	—		—		(16,580)		—		—		(16,580)		17		(16,563)
Other comprehensive income	—	—		—		—		—		7		7		—		7
Distributions to noncontrolling interests	—	—		—		—		—		—		—		(71)		(71)
Cash distributions declared ($0.0768 per share)	—	—		—		—		(13,360)		—		(13,360)		—		(13,360)

Balance at September 30, 2023	173,960	$	1,740	$	1,516,926	$	83,828	$	(842,667)	$	(9)	$	759,818	$	489	$	760,307

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)


	Nine Months Ended September 30,
	2024		2023
Operating activities:
Net cash flows provided by operating activities	$	30,965	$	24,616


Investing activities:


Capital expenditures	(9,165)		(10,463)
Purchase of held-to-maturity securities	—		(4,880)
Proceeds from maturity of short-term securities	—		15,000


Net cash flows used in investing activities	(9,165)		(343)
Financing activities:
Distributions to stockholders	(13,359)		(13,360)
Repayments on credit facilities	(10,000)		—

Purchase of interest rate cap	(100)		(3,211)
Principal payments on mortgages and other notes payable	(654)		(25,067)

Other financing activities	(14)		(512)
Net cash flows used in financing activities	(24,127)		(42,150)
Net decrease in cash and restricted cash	(2,327)		(17,877)
Cash and restricted cash at beginning of period	55,888		73,574
Cash and restricted cash at end of period	$	53,561	$	55,697

See accompanying notes to condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

1.Organization

CNL Healthcare Properties, Inc. (the “Company”) is a Maryland corporation that elected to be taxed as a real estate investment trust (“REIT”) for United States (“U.S.”) federal income tax purposes. The Company has been and intends to continue to be organized and operate in a manner that allows it to remain qualified as a REIT for U.S. federal income tax purposes. The Company conducts substantially all of its operations either directly or indirectly through: (1) an operating partnership, CHP Partners, LP (“Operating Partnership”), in which the Company is the sole limited partner and its wholly-owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned taxable REIT subsidiary (“TRS”), CHP TRS Holding, Inc.; (3) property owner and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

The Company is externally managed and advised by CNL Healthcare Corp. (“Advisor”), which is an affiliate of CNL Financial Group, LLC (“Sponsor”). The Sponsor is an affiliate of CNL Financial Group, Inc. (“CNL”). The Advisor is responsible for managing the Company’s day-to-day operations, serving as a consultant in connection with policy decisions to be made by the board of directors, and for identifying, recommending and executing on possible strategic alternatives and dispositions on the Company’s behalf pursuant to an advisory agreement among the Company, the Operating Partnership and the Advisor (as amended, the “Advisory Agreement”). Substantially all of the Company’s operating, administrative and certain property management services are provided by affiliates of the Advisor. In addition, certain property management services are provided by third-party property managers.

In 2017, the Company began evaluating possible strategic alternatives to provide liquidity to the Company’s stockholders. As part of executing under possible strategic alternatives, the Company’s board of directors committed to a plan to sell 70 properties, consisting of medical office buildings, post-acute care facilities, acute care hospitals and several skilled nursing facilities across the U.S. The Company completed the sale of the last of the 70 properties in 2022.

As of September 30, 2024, the Company’s seniors housing portfolio was geographically diversified with properties in 26 states and consisted of interests in 70 properties, including 69 seniors housing communities and one vacant land parcel. The Company has primarily leased its seniors housing properties to wholly-owned TRS entities and engaged independent third-party managers under management agreements to operate the properties under the RIDEA structures; however, the Company has also leased some of its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). In addition, most of the Company’s investments have been wholly owned, although, it has, to a lesser extent, invested through partnerships with other entities where it was believed to be appropriate and beneficial.

2.Summary of Significant Accounting Policies

Basis of Presentation and Consolidation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the nine months ended September 30, 2024 may not be indicative of the results that may be expected for the year ending December 31, 2024. Amounts as of December 31, 2023 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

The accompanying unaudited condensed consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest and the accounts of one variable interest entity (“VIE”) in which the Company is the primary beneficiary. All material intercompany accounts and transactions have been eliminated in consolidation.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

2.Summary of Significant Accounting Policies (continued)

Grant Income — In response to the coronavirus pandemic, the federal government and some states provided funds to providers of seniors housing communities under the CARES Act. These funds were deemed federal/state governmental grants and provided that the recipients attested to and complied with certain terms and conditions. Grant income is recognized upon receipt of the funds and when all the conditions of the grant have been met. During the nine months ended September 30, 2023, the Company recorded approximately $1.0 million as other income in the accompanying condensed consolidated statements of operations as all conditions of the grant had been met. The Company did not receive or recognize provider relief funds under the CARES Act during the quarter and nine months ended September 30, 2024.

Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments (when such impairments exist), the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor through March 2017 pursuant to the Advisor expense support agreement (the “Expense Support Agreement”). Accordingly, actual results could differ from those estimates.

Variable Interest Entities — As of September 30, 2024 and December 31, 2023, the Company had net assets in one subsidiary classified as a VIE. This subsidiary is a joint venture in which the Company’s equity interest consists of non-substantive protective voting rights. As of September 30, 2024, the Company determined it is the primary beneficiary and held a controlling financial interest in the subsidiary due to its power to direct the activities that most significantly impact the economic performance of this entity, as well as its obligation to absorb the losses and its right to receive benefits from this entity that could potentially be significant to this entity. As such, the transactions and accounts of this VIE are included in the accompanying condensed consolidated financial statements. The Company’s maximum exposure to loss as a result of its involvement with this VIE is limited to its net investment in this entity which totaled approximately $9.9 million as of September 30, 2024. The Company’s exposure is limited because of the non-recourse nature of the borrowings of this VIE.

Recent Accounting Pronouncements — In November 2023, the FASB issued ASU 2023-07, “Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280)”, which requires incremental disclosures related to a public entity’s reportable segments. This ASU is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact adopting ASU 2023-07 will have on the Company's consolidated financial statements and disclosures.

In December 2023, the FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures (Topic 740),” which requires entities to disclose in their rate reconciliation table additional categories of information about federal, state and foreign income taxes as well as additional information about reconciling items if certain quantitative thresholds are met. This ASU will require all entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has determined it will adopt this ASU on January 1, 2025, the adoption of which is not expected to have a material impact on the Company’s consolidated results of operations or cash flows.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

3.Revenue

The following table presents disaggregated revenue related to the Company’s resident fees and services during the quarter and nine months ended September 30, 2024 and 2023:


	Quarter Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	22.0	$	20.4	25.6	%	25.7	%
Assisted living	3,048	3,039	42.9		39.5		49.9		49.7
Memory care	923	932	16.8		15.5		19.6		19.5
Other revenues	—	—	4.2		4.1		4.9		5.1
	6,193	6,193	$	85.9	$	79.5	100.0	%	100.0	%

	Nine Months Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	64.9	$	60.0	25.7	%	25.5	%
Assisted living	3,048	3,039	125.3		117.1		49.7		49.9
Memory care	923	932	49.4		46.1		19.6		19.6
Other revenues	—	—	12.6		11.7		5.0		5.0
	6,193	6,193	$	252.2	$	234.9	100.0	%	100.0	%

4.Real Estate Assets, net

The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of September 30, 2024 and December 31, 2023 are as follows (in thousands):


	September 30, 2024		December 31, 2023
Land and land improvements	$	138,002	$	137,393
Building and building improvements	1,507,133		1,502,579
Furniture, fixtures and equipment	118,789		113,034
Less: accumulated depreciation	(511,463)		(473,869)
Real estate investment properties, net	$	1,252,461	$	1,279,137

Depreciation expense on the Company’s real estate investment properties, net was approximately $12.6 million and $37.7 million for the quarter and nine months ended September 30, 2024, respectively, and approximately $12.5 million and $37.6 million for the quarter and nine months ended September 30, 2023, respectively.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

5.Indebtedness

During the nine months ended September 30, 2024, the Company paid approximately $0.7 million in scheduled principal payments on its mortgages and other notes payable. In March 2024, the Company used cash on hand to pay down approximately $10.0 million of amounts outstanding under the Company’s revolving credit facility (the “2023 Revolving Credit Facility”).

In June 2024, the Company entered into a short-term interest rate cap for approximately $0.1 million, with a notional value of $8.0 million, a strike price of 3.0%, and a maturity date of January 2025 to hedge a portion of its interest rate exposure relating to $16.0 million in variable rate secured indebtedness. The fair value of this cash flow hedge of approximately $0.03 million is included in other assets in the accompanying condensed consolidated balance sheets as of September 30, 2024.

The following is a schedule of future principal payments for the Company’s total indebtedness for the remainder of 2024, each of the next four years and thereafter, in the aggregate, as of September 30, 2024 (in thousands):


2024	$	20,314
2025	308
2026	553,542
2027	—
2028	—
Thereafter	—
	$	574,164

The following table provides the details of the fair market value and carrying value of the Company’s indebtedness as of September 30, 2024 and December 31, 2023 (in millions):


	September 30, 2024				December 31, 2023
	Fair Value		Carrying Value		Fair Value		Carrying Value
Mortgages and other notes payable, net	$	36.2	$	36.0	$	36.8	$	36.6
Credit facilities, net (1)	$	538.0	$	533.8	$	548.0	$	541.8

______________________________

FOOTNOTE:

(1)The carrying value of credit facilities, net includes unamortized debt issuance costs of approximately $4.2 million and $6.2 million as of September 30, 2024 and December 31, 2023, respectively.

These fair market values are based on current rates and spreads the Company would expect to obtain for similar borrowings. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurement of the estimated fair values related to the Company’s mortgage notes payable and credit facilities is categorized as Level 3 on the three-level valuation hierarchy.

Generally, the loan agreements for the Company’s mortgage loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The loan agreements also contain customary events of default and remedies for the lenders. As of September 30, 2024, the Company was in compliance with all financial covenants related to its mortgage loans.

The Company’s senior unsecured term loan and the 2023 Revolving Credit Facility (collectively the “2023 Credit Facilities”) contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the 2023 Credit Facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 70% of adjusted FFO (as defined per the 2023 Credit Facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of September 30, 2024, the Company was in compliance with all financial covenants related to its 2023 Credit Facilities.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

6.Related Party Arrangements

The Company paid approximately $0.03 million and $0.10 million during each of the quarters and nine months ended September 30, 2024 and 2023, of cash distributions on Restricted Stock. These amounts have been recognized as compensation expense and included in general and administrative expenses in the accompanying condensed consolidated statements of operations. The termination of the Expense Support Agreement in June 2023 does not impact the previously issued Restricted Stock.

The expenses and fees incurred by and reimbursable to the Company’s related parties for the quarter and nine months ended September 30, 2024 and 2023, and related amounts unpaid as of September 30, 2024 and December 31, 2023 are as follows (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,				Unpaid amounts as of (1)
	2024		2023		2024		2023		September 30, 2024		December 31, 2023
Reimbursable expenses:
Operating expenses (2)	$	619	$	687	$	2,082	$	2,081	$	177	$	180
	619		687		2,082		2,081		177		180



Financing coordination fees (3)	—		—		—		163		—		—
Asset management fees	3,337		3,476		10,011		10,427		—		1,112
	$	3,956	$	4,163	$	12,093	$	12,671	$	177	$	1,292

______________________________

FOOTNOTES:

(1)Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.

(2)Amounts are recorded as general and administrative expenses in the accompanying condensed consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying condensed consolidated balance sheets in other assets.

(3)The Company did not incur any financing coordination fees during the quarter and nine months ended September 30, 2024. During the nine months ended September 30, 2023, the Company incurred financing coordination fees of approximately $0.2 million, related to the refinancing of the loan associated with five operating properties, all of which was expensed on the accompanying condensed consolidated statement of operations.

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)

7.Derivative Financial Instruments

The following summarizes the terms of the Company's interest rate caps and swaps and the corresponding asset (liability) as of September 30, 2024 and December 31, 2023 (in thousands):


Notional Amount(1)		Strike		Credit Spread(2)		Trade	Forward	Maturity Date	Fair Value Asset (Liability) as of
									September 30, 2024		December 31, 2023
Caps

$	8,000	3.50	%	2.60	%	6/29/2023	7/3/2023	1/1/2024	$	—	$	—
$	8,000	3.50	%	2.60	%	12/20/2023	1/2/2024	7/1/2024	$	—	$	63
$	8,000	3.00	%	2.60	%	6/28/2024	7/1/2024	1/2/2025	$	33	$	—
Swaps
$	267,000	4.40	%	2.35	%	12/7/2023	12/1/2023	12/1/2025	$	(2,193)	$	(1,678)
$	80,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(785)	$	(706)
$	20,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(197)	$	(177)

______________

FOOTNOTES:

(1)Amounts related to the interest rate caps and swaps held by the Company are recorded at fair value and included in other assets or other liabilities in the accompanying condensed consolidated balance sheets.

(2)The all-in rates are equal to the sum of the Strike and Credit Spread.

During the quarter and nine months ended September 30, 2024, the Company reclassified approximately $0.05 million and $0.1 million, respectively, from accumulated other comprehensive income (loss) into earnings related to the Company’s interest rate caps and during the quarter and nine months ended September 30, 2023, the Company reclassified approximately $1.0 million and $3.3 million, respectively. The net gain or loss reclassified into earnings from accumulated other comprehensive income (loss) is reported in interest expense and loan cost amortization in the condensed consolidated statements of operations. The amount that is expected to be reclassified from accumulated other comprehensive income (loss) into earnings in the next 12 months related to interest rate caps is approximately $0.03 million. No amounts related to the Company’s interest rate swaps have been reclassified into earnings during the quarter and nine months ended September 30, 2024, and the Company does not expect any amounts related to interest rate swaps to be reclassified into earnings in the next 12 months. The Company did not have any interest rate swaps in place during the quarter and nine months ended September 30, 2023.

Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative financial positions and has determined that such impact is not significant to the overall valuation of its derivative financial instruments. As a result, the Company determined that its derivative financial instruments valuation in its entirety is classified in Level 2 of the fair value hierarchy. Determining fair value requires management to make certain estimates and judgments. Changes in assumptions could have a positive or negative impact on the estimated fair values of such instruments which could, in turn, impact the Company’s results of operations.

8.Commitments and Contingencies

From time to time, the Company may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, its business, including proceedings to enforce its contractual or statutory rights. While the Company cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, the Company does not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on its results of operations or financial condition.

The Company’s Advisor has approximately 1.3 million contingently issuable Restricted Stock shares that were issued pursuant to the Expense Support Agreement. The Restricted Stock shares were treated as unissued for financial reporting purposes because the vesting criteria had not been met as of September 30, 2024. Refer to Note 6. “Related Party Arrangements” for information on distributions declared related to these Restricted Stock shares.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Caution Concerning Forward-Looking Statements

Statements contained under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q for the quarter and nine months ended September 30, 2024 that are not statements of historical or current fact may constitute “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbor created by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are statements that do not relate strictly to historical or current facts, but reflect management’s current understandings, intentions, beliefs, plans, expectations, assumptions and/or predictions regarding the future of the Company’s business and its performance, the economy, and other future conditions and forecasts of future events and circumstances. Forward-looking statements are typically identified by words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “continues,” “may,” “will,” “seeks,” and “could” and words and terms of similar substance in connection with discussions of future operating or financial performance, business strategy and portfolios, projected growth prospects, cash flows, costs and financing needs, legal proceedings, amount and timing of anticipated future distributions, estimated net asset value per share of the Company’s common stock, and/or other matters. The Company’s forward-looking statements are not guarantees of future performance. While the Company’s management believes its forward-looking statements are reasonable, such statements are inherently susceptible to uncertainty and changes in circumstances. As with any projection or forecast, forward-looking statements are necessarily dependent on assumptions, data and/or methods that may be incorrect or imprecise, and may not be realized. The Company’s forward-looking statements are based on management’s current expectations and a variety of risks, uncertainties and other factors, many of which are beyond the Company’s ability to control or accurately predict. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, the Company’s actual results could differ materially from those set forth in the forward-looking statements due to a variety of risks, uncertainties and other factors.

Important factors that could cause the Company's actual results to vary materially from those expressed or implied in its forward-looking statements include, but are not limited to government regulation, economic, strategic, political and social conditions and the following:

•the duration of recovery to occupancy from the COVID-19 pandemic;

•a worsening economic environment in the U.S. or globally, including continued or increasing inflation and financial market fluctuations;

•risks associated with the Company’s investment strategy, including its concentration in the seniors housing sector;

•the illiquidity of an investment in the Company’s stock;

•liquidation at less than the subscription price of the Company’s stock;

•the impact of regulations requiring periodic valuation of the Company on a per share basis, including the uncertainties inherent in such valuations and that the amount that a stockholder would ultimately realize upon liquidation may vary significantly from the Company’s estimated net asset value;

•risks associated with real estate markets, including declining real estate values and rising insurance costs;

•risks associated with reliance on the Company’s advisor and its affiliates, including conflicts of interest;

•the Company’s failure to repay, obtain, renew, refinance or extend necessary financing or to access the debt or equity markets;

•disruptions from cybersecurity incidents;

•costs resulting from damaging weather events and climate change;

•the use of debt to finance the Company’s business activities, including repayment, refinancing and interest rate risk and the Company’s failure to comply with debt covenants;

•competition for properties and/or tenants;

•defaults on or non-renewal of leases by tenants;

•failure to lease properties on favorable terms or at all;

•the impact of current and future environmental, zoning and other governmental regulations affecting the Company’s properties;

•the impact of changes in accounting rules;

•inaccuracies of the Company’s accounting estimates;

•unknown liabilities of acquired properties or liabilities caused by property managers or operators;

•material adverse actions or omissions by any joint venture partners;

•consequences of the Company’s net operating losses;

•increases in operating costs and other expenses;

•uninsured losses or losses in excess of the Company’s insurance coverage;

•the impact of outstanding and/or potential litigation;

•risks associated with the Company’s tax structuring; and

•failure to qualify for and maintain the Company’s qualification as a REIT for federal income tax purposes.

Given these uncertainties, the Company cautions you not to place undue reliance on forward-looking information.

For further information regarding risks and uncertainties associated with the Company’s business and other important factors that could cause the Company’s actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described in the Company’s reports filed from time to time with the SEC, including, but not limited to, the Company’s annual report on Form 10-K for the year ended December 31, 2023, a copy of which may be obtained from the Company’s website at www.cnlhealthcareproperties.com.

All written and oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this cautionary note. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to, and expressly disclaims any obligation to, publicly release the results of any revisions to its forward-looking statements to reflect new information, changed assumptions, the occurrence of unanticipated subsequent events or circumstances, or changes to future operating results over time, except as otherwise required by law.

Introduction

The following discussion is based on the condensed consolidated financial statements as of September 30, 2024 (unaudited) and December 31, 2023. Amounts as of December 31, 2023 included in the unaudited condensed consolidated balance sheets have been derived from the audited consolidated financial statements as of that date. This information should be read in conjunction with the accompanying unaudited condensed consolidated balance sheets and the notes thereto, as well as the audited consolidated financial statements, notes and management’s discussion and analysis included in our Annual Report on Form 10-K for the year ended December 31, 2023.

Overview

CNL Healthcare Properties, Inc. is a Maryland corporation that elected to be taxed as a REIT for U.S. federal income tax purposes. We have and intend to continue to be organized and operate in a manner that allows us to remain qualified as a REIT for federal income tax purposes. The terms “us,” “we,” “our,” “Company” and “CNL Healthcare Properties” include CNL Healthcare Properties, Inc. and each of its subsidiaries.

Substantially all of our assets are held by, and all operations are conducted, either directly or indirectly, through: (1) the Operating Partnership in which we are the sole limited partner and our wholly owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly owned TRS, CHP TRS Holding, Inc.; (3) property owner subsidiaries and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

We are externally managed and advised by CNL Healthcare Corp. (the “Advisor”). Our Advisor has responsibility for our day-to-day operations, serving as our consultant in connection with policy decisions to be made by our board of directors, and for identifying, recommending and executing on Possible Strategic Alternatives (as described below under “Possible Strategic Alternatives”), and dispositions on our behalf pursuant to an advisory agreement. For additional information on our Advisor, its affiliates or other related parties, as well as the fees and reimbursements we pay, see Note 6. “Related Party Arrangements.”

As of September 30, 2024, our seniors housing investment portfolio consisted of interests in 70 properties, consisting of a geographically diversified portfolio of 69 seniors housing communities and one vacant land parcel in 26 states. The types of seniors housing properties that we own include independent and assisted living facilities, continuing care retirement communities and Alzheimer’s/memory care facilities.

Possible Strategic Alternatives

In 2017, we began evaluating possible strategic alternatives to provide liquidity to our stockholders. In April 2018, our board of directors formed a special committee consisting solely of our independent directors (“Special Committee”) to consider possible strategic alternatives, including, but not limited to (i) the listing of our or one of our subsidiaries’ common stock on a national securities exchange; (ii) an orderly disposition of our assets or one or more of our asset classes and the distribution of the net sale proceeds thereof to our stockholders; and (iii) a potential business combination or other transaction with a third-party or parties that provides our stockholders with cash and/or securities of a publicly traded company (collectively, among other options, “Possible Strategic Alternatives”). Since 2018, the Special Committee has engaged KeyBanc Capital Markets Inc. to act as its financial advisor in connection with exploring our Possible Strategic Alternatives.

In connection with our consideration of the Possible Strategic Alternatives, our board of directors suspended both our Reinvestment Plan and our Redemption Plan effective July 11, 2018. In addition, as part of executing on Possible Strategic Alternatives, our board of directors committed to a plan to sell 70 properties, consisting of medical office buildings, post-acute care facilities, acute care hospitals and several skilled nursing facilities across the U.S. The Company completed the sale of the last of the 70 properties in 2022.

Our Special Committee continues to work with our financial advisor to carefully study market data. Economic and transactional environments were not conducive for dispositions or any type of large-scale deals in 2023 due to a volatile credit and debt capital markets, along with 11 interest rate increases by the Federal Reserve between March 2022 and July 2023. We remain fully committed to our readiness, active study and pursuit of additional Possible Strategic Alternatives to provide incremental liquidity to our stockholders when constructive market conditions return.

Seniors Housing Portfolio

Our remaining investment focus is in seniors housing communities. We have invested in or developed the following types of seniors housing properties:

Independent Living Facilities. Independent living facilities are age-restricted, multi-family rental or ownership (condominium) housing with central dining facilities that provide residents, as part of a monthly fee, meals and other services such as housekeeping, linen service, transportation, social and recreational activities.

Assisted Living Facilities. Assisted living facilities are usually state-regulated rental properties that provide the same services as independent living facilities, but also provide, in a majority of the units, supportive care from trained employees to residents who are unable to live independently and require assistance with activities of daily living. The additional services may include assistance with bathing, dressing, eating, and administering medications.

Memory Care/Alzheimer’s Facilities. Those suffering from the effects of Alzheimer’s disease or other forms of memory loss need specialized care. Memory care/Alzheimer’s centers provide the specialized care for this population including residential housing and assistance with the activities of daily living.

Portfolio Overview

As of September 30, 2024, our healthcare investment portfolio consisted of interests in 70 properties, comprising 69 seniors housing communities and one vacant land parcel.

We believe demographic trends and compelling supply and demand indicators present a strong case for an investment focus on seniors housing real estate and real estate-related assets. Our seniors housing investment portfolio is geographically diversified with properties in 26 states. The map below shows our seniors housing investment portfolio across geographic regions as of November 7, 2024:

CHP Portfolio Map - 70 Invest. as 11.07.2024.jpg

The following table summarizes our seniors housing investment portfolio by investment structure as of November 7, 2024:


Type of Investment	Number of Investments	Amount of Investments (in millions)		Percentage of Total Investments
Consolidated investments:
Seniors housing leased (1)	15	$	311.0	17.8	%
Seniors housing managed (2)	54	1,427.6		82.1
Vacant land	1	1.1		0.1
	70	$	1,739.7	100.0	%

________________________________

FOOTNOTES:

(1)Properties that are leased to third-party tenants for which we report rental income and related revenues.

(2)Properties that are leased to TRS entities and managed pursuant to third-party management contracts (i.e. RIDEA structure) where we report resident fees and services, and the corresponding property operating expenses.

Portfolio Evaluation

While we are not directly impacted by the performance of the underlying properties leased to third-party tenants, we believe that the financial and operational performance of our tenants provides an indication about the stability of our tenants and their ability to pay rent. To the extent that our tenants, managers or joint venture partners experience operating difficulties and become unable to generate sufficient cash to make rent payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Our tenants and managers are generally contractually required to provide this information to us in accordance with their respective lease, management and/or joint venture agreements. Therefore, in order to mitigate the aforementioned risk, we monitor our investments through a variety of methods determined by the type of property.

We monitor the credit of our tenants to stay abreast of any material changes in credit quality. We monitor credit quality by (1) reviewing financial statements that are required to be delivered to us under the applicable lease, (2) direct interaction with onsite property managers, (3) monitoring news and rating agency reports regarding our tenants (or their parent companies) and their underlying businesses, (4) monitoring the timeliness of rent collections and (5) monitoring lease coverage.

When evaluating the performance of our seniors housing portfolio, management reviews property-level operating performance versus budgeted expectations, conducts periodic operational review calls with operators and conducts periodic property inspections or site visits. Management also reviews occupancy levels and monthly revenue per occupied unit, which we define as total revenue divided by average number of occupied units. Similarly, when evaluating the performance of our third-party operators, management reviews monthly financial statements, property-level operating performance versus budgeted expectations, conducts periodic operational review calls with operators and conducts periodic property inspections or site visits. All of the aforementioned operating and statistical metrics assist us in determining the ability of our properties or operators to achieve market rental rates, to assess the overall performance of our diversified healthcare portfolio, and to review compliance with leases, debt, licensure, real estate taxes, and other collateral.

Significant Tenants and Operators

Our real estate portfolio of 69 seniors housing properties is operated by a mix of national or regional operators and the following represents the significant tenants and operators that lease or manage 10% or more of our rentable space as of November 7, 2024, excluding the vacant land parcel:


Tenants	Number of Properties	Rentable Square Feet (in thousands)	Percentage of Rentable Square Feet		Lease Expiration Year
TSMM Management, LLC	13	1,261	77.5	%	2025
Wellmore, LLC	2	366	22.5		2031-2032
	15	1,627	100.0	%

Operators	Number of Properties	Rentable Square Feet (in thousands)	Percentage of Rentable Square Feet		Operator Expiration Year
Integrated Senior Living, LLC	7	1,948	30.8	%	2024-2025
Prestige Senior Living, LLC	13	895	14.2		2026
Morningstar Senior Management, LLC	4	834	13.2		2024
Other operators (1)	30	2,645	41.8		2024-2029
	54	6,322	100.0	%

_____________________________

FOOTNOTE:

(1)Comprised of various operators, each of which comprise less than 10% of our consolidated rentable square footage.

Operator Expirations

As of November 7, 2024, we had 54 seniors housing properties managed by third-party operators. All of our management agreements have been in place for multiple years, and some include annual auto-renewal clauses which are effective unless a notice of termination is provided by either party. We work with our operators in advance of management agreement expirations or renewal period options in order for us to maintain a balanced operator rollover schedule, which provides us flexibility to execute on possible strategic alternatives, minimize potential early termination fees and align with the broader industry. The management agreements of 31 of our managed seniors housing properties are scheduled to expire within one year or less as of September 30, 2024, all of which are expected to be renewed.

Tenant Lease Expirations

As of September 30, 2024, we owned 15 seniors housing properties that were leased to third party tenants under triple-net operating leases. During the nine months ended September 30, 2024, our rental income represented approximately 7.5% of our total revenues.

Under the terms of our triple-net lease agreements, each tenant is responsible for payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof expenses. Each tenant is expected to pay real estate taxes directly to the taxing authorities. However, if the tenant does not pay the real estate taxes, we are liable.

We work with our tenants in advance of the lease expirations or renewal period options in order for us to maintain a balanced lease rollover schedule and high occupancy levels, as well as to enhance the value of our properties through extended lease terms. Certain amendments or modifications to the terms of existing leases could require lender approval.

The following table lists, on an aggregate basis, scheduled expirations for the remainder of 2024, each of the next nine years and thereafter on our consolidated seniors housing portfolio, assuming that none of the tenants exercise any of their renewal options (in thousands, except for number of properties and percentages):


Year of Expiration (1)	Number of Properties	Expiring Leased Square Feet	Expiring Annualized Base Rents (2)		Percentage of Expiring Annual Base Rents
2024	—	—	$	—	—	%
2025	13	1,261	18,781		67.8
2026	—	—	—		—
2027	—	—	—		—
2028	—	—	—		—
2029	—	—	—		—
2030	—	—	—		—
2031	1	137	3,821		13.8
2032	1	229	5,085		18.4
2033	—	—	—		—
Thereafter	—	—	—		—
Total	15	1,627	$	27,687	100.0	%

Weighted Average Remaining Lease Term: (3)			3.0 years

_______________________________

FOOTNOTES:

(1)Represents current lease expiration and does not take into consideration lease renewals available under existing leases at the option of the tenants.

(2)Represents the current base rent, excluding the impact of future rent increases included in leases, multiplied by 12 and included in the year of expiration.

(3)Weighted average remaining lease term is the average remaining term weighted by annualized current base rents.

Liquidity and Capital Resources

General

Our ongoing primary source of capital is proceeds from operating cash flows. Our primary uses of capital include the payment of distributions, payment of operating expenses, funding capital improvements to existing properties and payment of debt service. Generally, we expect to meet short-term working capital needs from our cash flows from operations. As necessary, we may use financings or other sources of capital in the event of unforeseen significant capital expenditures or to cover periodic shortfalls between distributions paid and cash flows from operating activities.

Weighted average occupancy was higher during the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023. Rate increases at our properties as part of ongoing resident lease renewals and improved occupancy, resulted in an increase in revenues during the nine months ended September 30, 2024. We expect that increases in occupancy and resident rate increases will continue and will increase revenue streams and NOI margins during the remainder of 2024.

As of September 30, 2024, we had approximately $112.5 million of liquidity (consisting of $50.5 million cash on hand and $62.0 million in undrawn availability under the 2023 Revolving Credit Facility). We remain focused on maintaining liquidity and financial flexibility and continue to focus on improving occupancy and implementing market rate increases while we continue to navigate through elevated labor costs and an elevated interest rate environment. The rate of revenue growth, elevated labor costs, volatility in the credit markets and the current interest rate environment have and may continue to impact our sources and uses of capital, financial condition, results of operations and cash flows.

We have pledged certain of our properties in connection with our borrowings and may continue to strategically leverage our real estate and use debt financing to provide additional funds for the payment of distributions to stockholders, working capital and for other corporate purposes. Our ability to increase our borrowings could be adversely affected by credit market conditions and the current interest rate environment, which could result in lenders reducing or limiting funds available for loans, including loans collateralized by real estate. We may also be negatively impacted by elevated interest rate levels on our unhedged variable rate debt or the timing of when we seek to refinance existing debt. As part of our variable debt hedging strategy, we have purchased interest rate caps and swaps for interest rate protection. We continue to monitor the credit markets and continue to evaluate the need and the timing for additional interest rate protection in the form of interest rate caps or swaps on unhedged variable rate debt or variable rate debt with interest rate protection scheduled to mature.

Sources of Liquidity and Capital Resources

Borrowings

There were no borrowings during the nine months ended September 30, 2024. During the nine months ended September 30, 2023, we refinanced a mortgage loan with the existing lender that consisted of $16.1 million of indebtedness secured by five properties that had a LIBOR based benchmark rate and was scheduled to mature in February 2024. In connection with the refinancing, we also amended certain terms and transitioned the benchmark rate for the mortgage loan from LIBOR to Term SOFR effective June 30, 2023, extended the maturity date from February 2024 to February 2026 and obtained two one-year extension options. We paid the Advisor a refinance fee of approximately $0.2 million related to this transaction. We may borrow money to fund enhancements to our portfolio, as well as to cover periodic shortfalls between distributions paid and cash flows from operating activities to the extent impacted by elevated labor costs, and an elevated interest rate environment.

Maturity of Short-Term Securities

As of December 31, 2022, we had invested approximately $24.2 million of available cash in held-to-maturity securities to enhance the yield earned on cash on hand. During the nine months ended September 30, 2023, we received approximately $15.0 million from the maturity of short-term securities and reinvested $4.9 million of these proceeds in short-term securities. All of our investments matured as of December 31, 2023, and we no longer have investments in short-term securities.

Net Cash Provided by Operating Activities

Cash flows from operating activities for the nine months ended September 30, 2024 and 2023 were approximately $31.0 million and $24.6 million, respectively. The change in cash flows from operating activities for the nine months ended September 30, 2024 as compared to the same period in 2023 was primarily the result of the following:

•an increase in property NOI, related to our seniors housing properties due to higher average occupancy and rate increases subsequent to September 30, 2023; partially offset by

•higher interest expense due to an increase in our weighted average interest costs from the refinancing of our 2023 Credit Facilities in December 2023.

Uses of Liquidity and Capital Resources

Capital Expenditures

We paid approximately $9.2 million and $10.5 million in capital expenditures during the nine months ended September 30, 2024 and 2023, respectively. We continue to invest in capital improvements to maintain and improve our properties.

Acquisition of Non-Controlling Interest

There were no acquisitions during the nine months ended September 30, 2024 or September 30, 2023. As of December 31, 2023, we indirectly owned one property through a 95% controlling interest in the Watercrest at Katy Joint Venture, our only subsidiary classified as a VIE. Effective November 1, 2024, we acquired the remaining 5% interest in the subsidiary from our non-controlling interest venture partner for approximately $1.5 million and as a result, own a 100% controlling interest in the Watercrest at Katy Joint Venture.

Purchase of Interest Rate Cap

During the nine months ended September 30, 2023, we paid approximately $3.1 million to purchase a short-term interest rate cap with a notional value of $420.0 million, a strike price of 3.5%, and a maturity date in August 2023, to hedge the majority of our variable rate interest exposure relating to the Credit Facilities. In December 2023, we refinanced our Credit Facilities, entered into the 2023 Credit Facilities and in conjunction therewith, entered into an interest rate swap with respect to our 2023 Credit Facilities that matures in December 2025. In addition, in June 2024, we entered into a short-term interest rate cap to replace an interest rate cap that matured in July 2024 relating to $16 million of variable rate secured indebtedness. We paid approximately $0.1 million for the interest rate cap, with a notional value of $8.0 million, a strike price of 3.0% and a maturity date of January 2025, to hedge a portion of our variable interest rate exposure. We earned $2.6 million and $3.2 million, respectively from the interest swap and interest rate cap counterparties related to variable rate debt during the nine months ended September 30, 2024 and 2023. These amounts are included in interest expense and loan costs amortization in the accompanying condensed consolidated statements of operations.

Debt Repayments

During the nine months ended September 30, 2024, we paid approximately $0.7 million in scheduled principal payments on our mortgages and other notes payable. In March 2024, we used cash on hand to pay down approximately $10.0 million of amounts outstanding under our 2023 Revolving Credit Facility. During the nine months ended September 30, 2023, we paid approximately $25.1 million of repayments on our mortgages and other notes payable, which included the repayment of a mortgage loan of approximately $22.8 million collateralized by one property in advance of its scheduled maturity of June 2023, the repayment of $1.4 million of unscheduled principal payments relating to a mortgage loan collateralized by five properties and $0.7 million of scheduled principal payments.

The following is a schedule of future principal payments for our total indebtedness for the remainder of 2024, each of the next four years and thereafter, in the aggregate, as of September 30, 2024 (in thousands):


2024	$	20,314
2025	308
2026	553,542
2027	—
2028	—
Thereafter	—
	$	574,164

As of September 30, 2024, we had approximately $112.5 million of liquidity (consisting of $50.5 million cash on hand and $62.0 million available under the 2023 Revolving Credit Facility) and were well positioned to manage our near-term debt maturities. As of September 30, 2024, we had $20.3 million of scheduled payments coming due during the remainder of 2024, which includes a mortgage loan of approximately $20.2 million, collateralized by one property, scheduled to mature in November 2024. We expect to borrow approximately $20.0 million under our 2023 Revolving Credit Facility to satisfy the obligation that will mature in mid-November 2024.

On an ongoing basis, we monitor our debt maturities, engage in dialogue with third-party lenders about various financing scenarios and analyze our overall portfolio borrowings in advance of scheduled maturity dates of the debt obligations to determine the optimal borrowing strategy.

The aggregate amount of long-term financing is not expected to exceed 60% of our gross asset values (as defined in our 2023 Credit Facilities agreement) on an annual basis. As of September 30, 2024 and December 31, 2023, we had aggregate debt leverage ratios of approximately 30.3% and 31.0%, respectively, of the aggregate gross carrying value of our assets.

Generally, the loan agreements for our mortgage loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The loan agreements also contain customary performance criteria and remedies for the lenders. As of September 30, 2024, we were in compliance with all financial covenants related to our mortgage loans.

The 2023 Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the 2023 Credit Facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 70% of adjusted FFO (as defined per the 2023 Credit Facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of September 30, 2024, the Company was in compliance with all financial covenants related to its 2023 Credit Facilities.

Distributions

In order to qualify as a REIT, we are required to make distributions, other than capital gain distributions, to our stockholders each year in the amount of at least 90% of our taxable income. We may make distributions in the form of cash or other property, including distributions of our own securities. While we generally expect to pay distributions from cash flows provided by operating activities, we have and may continue to cover periodic shortfalls between distributions paid and cash flows from operating activities with proceeds from other sources; such as from cash flows provided by financing activities, a component of which could include borrowings, whether collateralized by our properties or unsecured, or net sales proceeds from the sale of real estate.

The following table presents total cash distributions declared and cash distributions per share on a quarterly basis for the nine months ended September 30, 2024 and 2023 (in thousands, except per share data):


Periods	Cash Distributions per Share		Total Cash Distributions Declared (1)		Cash Flows Provided by Operating Activities (2)
2024 Quarters
First	$	0.02560	$	4,453	$	7,148
Second	0.02560		4,453		13,505
Third	0.02560		4,453		10,312
Total	$	0.07680	$	13,359	$	30,965

2023 Quarters
First	$	0.02560	$	4,453	$	5,328
Second	0.02560		4,453		11,415
Third	0.02560		4,454		7,873
Total	$	0.07680	$	13,360	$	24,616

_______________________________

FOOTNOTES:

(1)For the nine months ended September 30, 2024 and 2023, our net loss attributable to common stockholders was approximately $9.5 million and $16.6 million, respectively, while total cash distributions declared were approximately $13.4 million and $13.4 million, respectively. For the nine months ended September 30, 2024 and 2023, approximately 100% of cash distributions declared to stockholders were considered to be funded with cash provided by operating activities as calculated on a quarterly basis for GAAP purposes.

(2)Cash flows from operating activities calculated in accordance with GAAP are not necessarily indicative of the amount of cash available to pay distributions and as such our board of directors uses other measures such as FFO and MFFO in order to evaluate the level of distributions.

Results of Operations

Except for the impact of an elevated interest rate environment, we are not aware of other material trends or uncertainties, favorable or unfavorable, that may be reasonably anticipated to have a material impact on either capital resources or the revenues or income to be derived from the operation of properties, other than those referred to in the risk factors identified in “Part II, Item 1A” of this report and the “Risk Factors” section of our Annual Report.

The following discussion and analysis should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the notes thereto.

Quarter and nine months ended September 30, 2024 as compared to the quarter and nine months ended September 30, 2023

As of September 30, 2024 and 2023, excluding our vacant land, we owned 69 consolidated operating investment properties, respectively.


	Investment count as of September 30,
Consolidated operating investment types:	2024	2023
Seniors housing leased	15	15
Seniors housing managed	54	54

	69	69

Rental Income and Related Revenues. Rental income and related revenues were approximately $6.9 million and $20.5 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $6.7 million and $20.2 million for the quarter and nine months ended September 30, 2023, respectively.

Resident Fees and Services. Resident fees and services income was approximately $85.9 million and $252.2 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $79.5 million and $234.9 million for the quarter and nine months ended September 30, 2023, respectively. The increase in revenue during the quarter and nine months ended September 30, 2024, as compared to the quarter and nine months ended September 30, 2023, was primarily due to an increase in average occupancy and increases in rates charged to our residents.

Property Operating Expenses. Property operating expenses were approximately $62.6 million and $181.8 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $59.4 million and $175.7 million for the quarter and nine months ended September 30, 2023, respectively. Property operating expenses increased during the quarter and nine months ended September 30, 2024, as compared to the quarter and nine months ended September 30, 2023, primarily due to an increase in average occupancy.

General and Administrative Expenses. General and administrative expenses were approximately $1.8 million and $6.3 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $2.0 million and $6.6 million for the quarter and nine months ended September 30, 2023, respectively. General and administrative expenses were comprised primarily of personnel expenses of affiliates of our Advisor, directors’ and officers’ insurance, franchise taxes, sales taxes, accounting and legal fees, and board of director fees.

Asset Management Fees. We incurred asset management fees of approximately $3.3 million and $10.0 million for the quarter and nine months ended September 30, 2024 , respectively, as compared to approximately $3.5 million and $10.4 million for the quarter and nine months ended September 30, 2023, respectively.

Property Management Fees. We incurred property management fees payable to our third-party property managers of approximately $4.3 million and $12.4 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $3.9 million and $11.5 million for the quarter and nine months ended September 30, 2023, respectively. The property management fees are based on a percentage of revenues under the property management agreement and the increase across periods is reflective of the increase in average occupancy and resident fees and service revenue over the same period as described above.

Financing Coordination Fees. We did not incur any financing coordination fees for the quarter and nine months ended September 30, 2024. We incurred financing coordination fees of approximately $0.2 million for the nine months ended September 30, 2023 related to the refinancing of the loan associated with five operating properties.

Depreciation and Amortization. Depreciation and amortization expenses were approximately $12.6 million and $37.8 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $12.5 million and $38.7 million for the quarter and nine months ended September 30, 2023, respectively. Depreciation and amortization expenses are comprised of depreciation and amortization of the buildings, equipment, land improvements and in-place leases related to our real estate portfolio. The decrease during the nine months ended September 30, 2024 was primarily due to in-place lease intangibles from the January 1, 2022 consolidation of the Windsor Manor assets becoming fully amortized during the nine months ended September 30, 2023.

Interest and Other Income. Interest and other income was approximately $0.4 million and $0.9 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $0.5 million and $2.5 million for the quarter and nine months ended September 30, 2023, respectively. Interest and other income included approximately $0.1 million and $1.0 million in federal/state governmental grants recognized during the quarter and nine months ended September 30, 2023, respectively. In response to the coronavirus pandemic, the federal government and some states provided funds to providers of seniors housing communities. We recorded these grant funds as other income in the accompanying condensed consolidated statements of operations as all conditions of the grant had been met. We did not receive or recognize grant funds during the quarter and nine months ended September 30, 2024.

Interest Expense and Loan Cost Amortization. Interest expense and loan cost amortization were approximately $11.5 million and $34.6 million for the quarter and nine months ended September 30, 2024, respectively, as compared to approximately $10.8 million and $30.7 million for the quarter and nine months ended September 30, 2023, respectively. The increase in interest expense and loan cost amortization was primarily due to an increase in our weighted average interest costs from the refinancing of our 2023 Credit Facilities in December 2023 and an increase in the amortization of debt issuance cost incurred as part of the refinancing. During the quarter and nine months ended September 30, 2024 and 2023, we were able to partially mitigate the full impact from the rise in interest rates due to the interest rate protection in place as part of our overall variable debt hedging strategy.

Net Operating Income

We generally expect to meet future cash needs for general and administrative expenses, debt service and distributions from NOI. We define NOI, a non-GAAP measure, as total revenues less the property operating expenses and property management fees from managed properties. We use NOI as a key performance metric for internal monitoring and planning purposes, including the preparation of annual operating budgets and monthly operating reviews, as well as to facilitate analysis of future investment and business decisions. It does not represent cash flows from operating activities in accordance with GAAP and should not be considered to be an alternative to net income or loss (determined in accordance with GAAP) as an indication of our operating performance or to be an alternative to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity. We believe the presentation of this non-GAAP measure is important to the understanding of our operating results for the periods presented because it is an indicator of the return on property investment and provides a method of comparing property performance over time. We aggregate NOI on a “same store” basis for comparable properties that we have owned during the entirety of all periods presented. The chart below presents a reconciliation of our net income to NOI for the quarter and nine months ended September 30, 2024 and 2023 (in thousands) and the amount invested in properties as of September 30, 2024 and 2023 (in millions):


	Quarter Ended								Nine Months Ended
	September 30,				Change				September 30,				Change
	2024		2023		$		%		2024		2023		$		%
Net loss	$	(3,155)	$	(5,399)					$	(9,468)	$	(16,563)
Adjusted to exclude:
General and administrative expenses	1,841		2,015						6,251		6,569
Asset management fees	3,337		3,476						10,011		10,427
Financing coordination fees	—		—						—		163
Depreciation and amortization	12,619		12,471						37,785		38,741

Other expense	11,171		10,256						33,619		28,170
Income tax expense	125		118						363		321



Same Store NOI	$	25,938	$	22,937	$	3,001	13.1	%	$	78,561	$	67,828	$	10,733	15.8	%
Invested in operating properties, end of period (in millions)	$	1,739	$	1,739					$	1,739	$	1,739

Overall, our NOI for the quarter and nine months ended September 30, 2024 increased by approximately $3.0 million and $10.7 million, respectively, as compared to the quarter and nine months ended September 30, 2023. NOI increased primarily due to an increase in average occupancy and increases in rates charged to our residents during the quarter and nine months ended September 30, 2024, partially offset by higher operating expenses.

Funds from Operations and Modified Funds from Operations

Due to certain unique operating characteristics of real estate companies, as discussed below, the National Association of Real Estate Investment Trusts, (“NAREIT”) promulgated a measure known as funds from operations (“FFO”), which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to net income or loss as determined under GAAP.

We define FFO, a non-GAAP measure, consistent with the standards approved by the Board of Governors of NAREIT. NAREIT defines FFO as net income or loss computed in accordance with GAAP, excluding gains or losses from sales of property, real estate asset impairment write-downs, plus depreciation and amortization of real estate related assets, and after adjustments for unconsolidated partnerships and joint ventures. Our FFO calculation complies with NAREIT’s policy described above.

The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, which implies that the value of real estate assets diminishes predictably over time, especially if such assets are not adequately maintained or repaired and renovated as required by relevant circumstances and/or is requested or required by lessees for operational purposes in order to maintain the value of the property. We believe that, because real estate values historically rise and fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation may be less informative. Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization, provides a more complete understanding of our performance to investors and to management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income or loss. However, FFO and MFFO, as described below, should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income or loss in its applicability in evaluating operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and MFFO measures and the adjustments to GAAP in calculating FFO and MFFO.

Changes in the accounting and reporting promulgations under GAAP (for acquisition fees and expenses for business combinations from a capitalization/depreciation model) to an expensed-as-incurred model that were put into effect in 2009, and other changes to GAAP accounting for real estate subsequent to the establishment of NAREIT’s definition of FFO, have prompted an increase in cash-settled expenses, specifically acquisition fees and expenses, as items that are expensed under GAAP and accounted for as operating expenses. Our management believes these fees and expenses do not affect our overall long-term operating performance. Publicly registered, non-listed REITs typically have a significant amount of acquisition activity and are substantially more dynamic during their initial years of investment and operation. While other start up entities may also experience significant acquisition activity during their initial years, we believe that non-listed REITs are unique in that they have a limited life with targeted exit strategies within a relatively limited time frame after acquisition activity ceases. Due to the above factors and other unique features of publicly registered, non-listed REITs, the IPA has standardized a measure known as modified funds from operations (“MFFO”) which the IPA has recommended as a supplemental measure for publicly registered non-listed REITs and which we believe to be another appropriate supplemental measure to reflect the operating performance of a non-listed REIT. MFFO is not equivalent to our net income or loss as determined under GAAP, and MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate with a limited life and targeted exit strategy, as currently intended. We believe that because MFFO excludes costs that we consider more reflective of investing activities and other non-operating items included in FFO and also excludes acquisition fees and expenses that affect our operations only in periods in which properties are acquired, MFFO can provide, on a going forward basis, an indication of the sustainability (that is, the capacity to continue to be maintained) of our operating performance after the period in which we acquired our properties and once our portfolio is in place. By providing MFFO, we believe we are presenting useful information that assists investors and analysts to better assess the sustainability of our operating performance after our properties have been acquired. We also believe that MFFO is a recognized measure of sustainable operating performance by the non-listed REIT industry.

We define MFFO, a non-GAAP measure, consistent with the IPA’s Guideline 2010-01, Supplemental Performance Measure for Publicly Registered, Non-Listed REITs: MFFO, or the Practice Guideline, issued by the IPA in November 2010. The Practice Guideline defines MFFO as FFO further adjusted for the following items, as applicable, included in the determination of GAAP net income or loss: acquisition fees and expenses; amounts relating to deferred rent receivables and amortization of above and below market leases and liabilities (which are adjusted from a GAAP accrual basis in order to reflect such payments on a cash basis of amounts expected to be received for such lease and rental payments); contingent purchase price consideration adjustments; accretion of discounts and amortization of premiums on debt investments; mark-to-market adjustments included in net income or loss; gains or losses included in net income from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and unrealized gains or losses resulting from consolidation from, or deconsolidation to, equity accounting and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect MFFO on the same basis. The accretion of discounts and amortization of premiums on debt investments, unrealized gains and losses on hedges, foreign exchange, derivatives or securities holdings, unrealized gains and losses resulting from consolidations, as well as other listed cash flow adjustments are adjustments made to net income or loss in calculating the cash flows provided by operating activities and, in some cases, reflect gains or losses which are unrealized and may not ultimately be realized.

Our MFFO calculation complies with the IPA’s Practice Guideline described above. In calculating MFFO, we exclude acquisition related expenses. Under GAAP, acquisition fees and expenses are characterized as operating expenses in determining operating net income or loss. These expenses are paid in cash by us. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property.

Our management uses MFFO and the adjustments used to calculate it in order to evaluate our performance against other non-listed REITs which have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. As noted above, MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate in this manner. We believe that our use of MFFO and the adjustments used to calculate it allow us to present our performance in a manner that reflects certain characteristics that are unique to non-listed REITs, such as their limited life, limited and defined acquisition period and targeted exit strategy, and hence that the use of such measures is useful to investors. For example, acquisition costs are funded from our subscription proceeds and other financing sources and not from operations.

By excluding expensed acquisition costs, the use of MFFO provides information consistent with management’s analysis of the operating performance of the properties.

Presentation of this information is intended to provide useful information to investors as they compare the operating performance of different non-listed REITs, although it should be noted that not all REITs calculate FFO and MFFO the same way and as such comparisons with other REITs may not be meaningful. Furthermore, FFO and MFFO are not necessarily indicative of cash flows available to fund cash needs and should not be considered as an alternative to net income (or loss) or income (or loss) from continuing operations as an indication of our performance, as an alternative to cash flows from operations, as an indication of our liquidity, or indicative of funds available to fund our cash needs including our ability to make distributions to our stockholders. FFO and MFFO should be reviewed in conjunction with other GAAP measurements as an indication of our performance. MFFO is useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods.

Neither the SEC, NAREIT nor any other regulatory body has passed judgment on the acceptability of the adjustments we use to calculate FFO or MFFO. In the future, the SEC, NAREIT or another regulatory body may decide to standardize the allowable adjustments across the non-listed REIT industry and we would have to adjust our calculation and characterization of FFO or MFFO.

The following table presents a reconciliation of net income to FFO and MFFO for the quarter and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net loss attributable to common stockholders	$	(3,174)	$	(5,414)	$	(9,511)	$	(16,580)
Adjustments:
Depreciation and amortization	12,619		12,471		37,785		38,741


FFO adjustments attributable to noncontrolling interests	(12)		(13)		(36)		(37)
FFO attributable to common stockholders	9,433		7,044		28,238		22,124
Straight-line rent adjustments(1)	513		436		1,331		1,334
Amortization of premium for debt investments	—		—		—		(17)
Realized loss on extinguishment of debt(2)	—		—		—		11
MFFO adjustments attributable to noncontrolling interests	—		(2)		(1)		(4)
MFFO attributable to common stockholders	$	9,946	$	7,478	$	29,568	$	23,448
Weighted average number of shares of common stock outstanding (basic and diluted)	173,942		173,960		173,942		173,960
Net loss per share (basic and diluted)	$	(0.02)	$	(0.03)	$	(0.05)	$	(0.10)
FFO per share (basic and diluted)	$	0.05	$	0.04	$	0.16	$	0.13
MFFO per share (basic and diluted)	$	0.06	$	0.04	$	0.17	$	0.13

______________________________

FOOTNOTES:

(1)Under GAAP, rental receipts are allocated to periods using various methodologies. This may result in income or expense recognition that is significantly different than underlying contract terms. By adjusting for these items (from a GAAP accrual basis in order to reflect such payments on a cash basis of amounts expected to be received for such lease and rental payments), MFFO provides useful supplemental information on the realized economic impact of lease terms and debt investments, providing insight on the contractual cash flows of such lease terms and debt investments, and aligns results with management’s analysis of operating performance.

(2)Management believes that adjusting for the realized loss on the extinguishment of debt, hedges or other derivatives is appropriate because the adjustments are not reflective of our ongoing operating performance and, as a result, the adjustments better align results with management’s analysis of operating performance.

Related Party Transactions

See Item 1. “Condensed Consolidated Financial Information” and our Annual Report on Form 10-K for the year ended December 31, 2023 for a summary of our related party transactions.

Critical Accounting Policies and Estimates

See Item 1. “Condensed Consolidated Financial Information” and our Annual Report on Form 10-K for the year ended December 31, 2023 for a summary of our critical accounting policies and estimates.

Recent Accounting Pronouncements

See Item 1. “Condensed Consolidated Financial Information” for a summary of the impact of recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures about Market Risks

We may be exposed to interest rate changes primarily as a result of the long-term debt we used to acquire properties and other permitted investments, as well as impacts of volatile credit markets and an elevated interest rate environment. Our management objectives related to interest rate risk are to limit the impact of interest rate changes on earnings and on operating cash flows. To achieve our objectives, we borrow at fixed rates or variable rates with the lowest margins available, and in some cases, with the ability to convert from variable rates to fixed rates. With regard to variable rate financing, we assess interest rate cash flow risk by continually identifying and monitoring changes in interest rate exposures that may adversely impact expected future cash flows and by evaluating hedging opportunities.

The following is a schedule as of September 30, 2024 of our fixed and variable rate debt maturities for the remainder of 2024, and each of the next four years and thereafter (principal maturities only) (in thousands):


	Expected Maturities
	2024			2025			2026			2027			2028			Thereafter			Total			Fair Value(1)
Fixed rate debt	$	20,239		$	—		$	—		$	—		$	—		$	—		$	20,239		$	20,239
Weighted average interest rate on fixed rate debt	3.25		%	—		%	—		%	—		%	—		%	—		%	3.25		%
Variable rate debt	$	75		$	308		$	553,542		$	—		$	—		$	—		$	553,925		$	553,912
Average interest rate on variable rate debt(2)	2.36% +Term SOFR			2.36% +Term SOFR			2.36% +Term SOFR			—			—			—			2.36% +Term SOFR

____________

FOOTNOTES:

(1)The estimated fair value of our fixed and variable rate debt was determined using discounted cash flows based on market interest rates as of September 30, 2024. We determined market rates through discussions with our existing lenders by pricing our loans with similar terms and current rates and spreads.

(2)Term SOFR is defined in the respective debt agreement.

Management estimates that a hypothetical one-percentage point increase in variable rates compared to variable rates as of September 30, 2024, disregarding the impact of our interest rate protection in place, would increase interest expense by approximately $5.5 million on an annualized basis based on variable rate debt outstanding as of September 30, 2024. This sensitivity analysis contains certain simplifying assumptions, and although it gives an indication of our exposure to changes in interest rates, it is not intended to predict future results and actual results will likely vary given that our sensitivity analysis on the effects of changes in SOFR does not factor in a potential change in variable rate debt levels or interest rate protection provided by interest rate caps and swaps.

As of September 30, 2024, the Company’s debt is comprised of approximately 3.5% in fixed rate debt, approximately 65.3% in variable rate debt with current interest rate protection and approximately 31.2% of unhedged variable rate debt. The remaining unhedged variable rate debt primarily relates to our 2023 Credit Facilities. Overall, we believe longer term fixed rate debt could be beneficial in a rising interest rate or rising inflation rate environment and as such we continue to evaluate the need for additional interest rate protection on our unhedged variable rate debt or variable rate debt with interest rate protection scheduled to mature.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Exchange Act, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to provide reasonable assurance that material information required to be included in our periodic SEC reports is recorded, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms.

Changes in Internal Control over Financial Reporting

During the most recent fiscal quarter, there were no changes in our internal controls over financial reporting (as defined under Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, our business, including proceedings to enforce our contractual or statutory rights. While we cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, we do not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on our results of operations or financial condition.

Item 1A. Risk Factors

There have been no material changes in our assessment of our risk factors from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities – None

Issuer Purchases of Equity Securities – None

Secondary Sales of Registered Shares between Investors

During the nine months ended September 30, 2024 and 2023, there were approximately 1,754,000 shares and 1,560,000 shares transferred between investors, respectively, at an average sales price per share of approximately $3.69 and $4.64, respectively. We are not aware of any other trades of our shares, other than previous purchases made in our Offerings and/or redemptions of shares by us.

Item 3. Defaults Upon Senior Securities – None

Item 4. Mine Safety Disclosure – Not Applicable

Item 5. Other Information – None

Item 6. Exhibits

The exhibits required by this item are set forth in the Exhibit Index attached hereto and are filed or incorporated as part of this report.

EXHIBIT INDEX

Exhibits

The following exhibits are included, or incorporated by reference in this Quarterly Report on Form 10-Q for the quarter and nine months ended September 30, 2024 (and are numbered in accordance with Item 601 of Regulation S-K).


Exhibit No.						Description

3.1						Third Articles of Amendment and Restatement of CNL Healthcare Properties, Inc. (Previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed July 25, 2016 and incorporated herein by reference.)
3.2						Third Amended and Restated Bylaws of CNL Healthcare Properties, Inc., effective June 27, 2013. (Previously filed as Exhibit 3.2 to the Current Report on Form 8-K filed July 2, 2013 and incorporated herein by reference.)
4.1						Statement regarding restrictions on transferability of shares of common stock (to appear on stock certificate or to be sent upon request and without charge to stockholders issued shares without certificates). (Previously filed as Exhibit 4.5 to the Pre-effective Amendment One to the Registration Statement on Form S-11 (File No. 333-168129) filed October 20, 2010 and incorporated herein by reference.)
31.1						Certification of Chief Executive Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
31.2						Certification of Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
32.1						Certification of Chief Executive Officer and Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
101						The following materials from CNL Healthcare Properties, Inc. Quarterly Report on Form 10-Q for the quarter and nine months ended September 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language); (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Loss, (iv) Condensed Consolidated Statements of Stockholders’ Equity and Redeemable Noncontrolling Interest, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.
104						Cover Page Interactive Data File included as Exhibit 101 (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on the 8th day of November 2024.


CNL HEALTHCARE PROPERTIES, INC.

By:			/s/ Stephen H. Mauldin
			STEPHEN H. MAULDIN
			Chief Executive Officer and President
			(Principal Executive Officer)


By:			/s/ Ixchell C. Duarte
			IXCHELL C. DUARTE
			Chief Financial Officer, Senior Vice President and Treasurer
			(Principal Financial Officer and Principal Accounting Officer)

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

OF CNL HEALTHCARE PROPERTIES, INC.

PURSUANT TO RULE 13a-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen H. Mauldin, certify that:

1.I have reviewed this quarterly report on Form 10-Q of CNL Healthcare Properties, Inc. (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 8, 2024

By:

/s/ Stephen H. Mauldin

Stephen H. Mauldin

Chief Executive Officer and President

(Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

OF CNL HEALTHCARE PROPERTIES, INC.

PURSUANT TO RULE 13a-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ixchell C. Duarte, certify that:

1.I have reviewed this quarterly report on Form 10-Q of CNL Healthcare Properties, Inc. (the “Registrant”);

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 8, 2024

By:

/s/ Ixchell C. Duarte

Ixchell C. Duarte

Chief Financial Officer, Senior Vice President and Treasurer
(Principal Financial Officer and Principal Accounting Officer)

EXHIBIT 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of CNL Healthcare Properties, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024, as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen H. Mauldin, Chief Executive Officer and President, and Ixchell C. Duarte, Chief Financial Officer, Senior Vice President and Treasurer of the Company, each certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 8, 2024

By:

/s/ Stephen H. Mauldin

Stephen H. Mauldin

Chief Executive Officer and President

Date: November 8, 2024

By:

/s/ Ixchell C. Duarte

Ixchell C. Duarte

Chief Financial Officer, Senior Vice President and Treasurer

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2024	Nov. 07, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	000-54685
Entity Registrant Name	CNL Healthcare Properties, Inc.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	27-2876363
Entity Address, Address Line One	CNL Center at City Commons
Entity Address, Address Line Two	450 South Orange Avenue
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32801
City Area Code	407
Local Phone Number	650-1000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		175,274,045
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001496454
Current Fiscal Year End Date	--12-31

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
ASSETS
Real estate investment properties, net (including one VIE $29,986 and $30,041, respectively)	$ 1,252,461	$ 1,279,137
Cash (including one VIE $1,819 and $1,515, respectively)	50,516	54,097
Restricted cash (including one VIE $459 and $8, respectively)	3,045	1,791
Other assets (including one VIE $142 and $246, respectively)	18,918	19,127
Deferred rent, lease incentives and intangibles, net	10,366	11,386
Total assets	1,335,306	1,365,538
Liabilities:
Mortgages and other notes payable, net (including one VIE $20,219 and $20,622, respectively)	36,017	36,569
Credit facilities, net	533,752	541,840
Accounts payable and accrued liabilities (including one VIE $1,439 and $1,411, respectively)	32,073	31,322
Total liabilities	614,714	621,498
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding	0	0
Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.01 par value per share, 1,120,000 shares authorized, 187,958 shares issued and 175,274 shares outstanding	1,739	1,739
Capital in excess of par value	1,516,806	1,516,806
Accumulated income	65,199	74,710
Accumulated distributions	(860,479)	(847,120)
Accumulated other comprehensive loss	(3,193)	(2,572)
Total stockholders' equity	720,072	743,563
Noncontrolling interest	520	477
Total equity	720,592	744,040
Total liabilities and equity	1,335,306	1,365,538
Nonrelated Party
Liabilities:
Other liabilities/Due to related parties	12,695	10,475
Related Party
Liabilities:
Other liabilities/Due to related parties	$ 177	$ 1,292

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
ASSETS
Real estate investment properties, net	$ 1,252,461	$ 1,279,137
Cash	50,516	54,097
Restricted cash	3,045	1,791
Other assets	18,918	19,127
Liabilities:
Mortgages and other notes payable, net	36,017	36,569
Accounts payable and accrued liabilities	$ 32,073	$ 31,322
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Excess shares, par value (in dollars per share)	$ 0.01	$ 0.01
Excess shares, shares authorized (in shares)	300,000,000	300,000,000
Excess shares, shares issued (in shares)	0	0
Excess shares, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,120,000,000	1,120,000,000
Common stock, shares issued (in shares)	187,958,000	187,958,000
Common stock, shares outstanding (in shares)	175,274,000	175,274,000
Variable Interest Entity, Primary Beneficiary
ASSETS
Real estate investment properties, net	$ 29,986	$ 30,041
Cash	1,819	1,515
Restricted cash	459	8
Other assets	142	246
Liabilities:
Mortgages and other notes payable, net	20,219	20,622
Accounts payable and accrued liabilities	1,439	1,411
Other liabilities	$ 318	$ 216

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Rental income and related revenues	$ 6,920	$ 6,730	$ 20,539	$ 20,166
Resident fees and services	85,877	79,483	252,223	234,892
Total revenues	92,797	86,213	272,762	255,058
Operating expenses:
Property operating expenses	62,582	59,395	181,772	175,687
General and administrative expenses	1,841	2,015	6,251	6,569
Financing coordination fees	0	0	0	163
Depreciation and amortization	12,619	12,471	37,785	38,741
Total operating expenses	84,656	81,238	248,248	243,130
Operating income	8,141	4,975	24,514	11,928
Other income (expense):
Interest and other income	356	506	945	2,510
Interest expense and loan cost amortization	(11,527)	(10,762)	(34,564)	(30,680)
Total other expense	(11,171)	(10,256)	(33,619)	(28,170)
Loss before income taxes	(3,030)	(5,281)	(9,105)	(16,242)
Income tax expense	(125)	(118)	(363)	(321)
Net loss	(3,155)	(5,399)	(9,468)	(16,563)
Less: Amounts attributable to noncontrolling interests	19	15	43	17
Net loss attributable to common stockholders	$ (3,174)	$ (5,414)	$ (9,511)	$ (16,580)
Net loss per share of common stock, basic (in dollars per share)	$ (0.02)	$ (0.03)	$ (0.05)	$ (0.10)
Net loss per share of common stock, diluted (in dollars per share)	$ (0.02)	$ (0.03)	$ (0.05)	$ (0.10)
Weighted average number of shares of common stock outstanding, basic (in shares)	173,942	173,960	173,942	173,960
Weighted average number of shares of common stock outstanding, diluted (in shares)	173,942	173,960	173,942	173,960
Asset management fees
Operating expenses:
Management fees	$ 3,337	$ 3,476	$ 10,011	$ 10,427
Property management fees
Operating expenses:
Management fees	$ 4,277	$ 3,881	$ 12,429	$ 11,543

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (3,155)	$ (5,399)	$ (9,468)	$ (16,563)
Other comprehensive (loss) income:
Unrealized (loss) gain on derivative financial instruments, net	(4,561)	56	(621)	7
Total other comprehensive (loss) income	(4,561)	56	(621)	7
Comprehensive loss	(7,716)	(5,343)	(10,089)	(16,556)
Less: Comprehensive income attributable to noncontrolling interest	19	15	43	17
Comprehensive loss attributable to common stockholders	$ (7,735)	$ (5,358)	$ (10,132)	$ (16,573)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Total Stockholders' Equity	Common Stock	Capital in Excess of Par Value	Accumulated Income	Accumulated Distributions	Accumulated Other Comprehensive Income (Loss)	Non- controlling Interest
Beginning balance (in shares) at Dec. 31, 2022			173,960
Beginning balance at Dec. 31, 2022	$ 790,294	$ 789,751	$ 1,740	$ 1,516,926	$ 100,408	$ (829,307)	$ (16)	$ 543
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(16,563)	(16,580)			(16,580)			17
Other comprehensive (loss) income	7	7					7
Distributions to noncontrolling interests	(71)							(71)
Cash distributions declared	(13,360)	(13,360)				(13,360)
Ending balance (in shares) at Sep. 30, 2023			173,960
Ending balance at Sep. 30, 2023	760,307	759,818	$ 1,740	1,516,926	83,828	(842,667)	(9)	489
Beginning balance (in shares) at Jun. 30, 2023			173,960
Beginning balance at Jun. 30, 2023	770,117	769,630	$ 1,740	1,516,926	89,242	(838,213)	(65)	487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(5,399)	(5,414)			(5,414)			15
Other comprehensive (loss) income	56	56					56
Distributions to noncontrolling interests	(13)							(13)
Cash distributions declared	(4,454)	(4,454)				(4,454)
Ending balance (in shares) at Sep. 30, 2023			173,960
Ending balance at Sep. 30, 2023	$ 760,307	759,818	$ 1,740	1,516,926	83,828	(842,667)	(9)	489
Beginning balance (in shares) at Dec. 31, 2023	175,274		173,942
Beginning balance at Dec. 31, 2023	$ 744,040	743,563	$ 1,739	1,516,806	74,710	(847,120)	(2,572)	477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(9,468)	(9,511)			(9,511)			43
Other comprehensive (loss) income	(621)	(621)					(621)
Cash distributions declared	$ (13,359)	(13,359)				(13,359)
Ending balance (in shares) at Sep. 30, 2024	175,274		173,942
Ending balance at Sep. 30, 2024	$ 720,592	720,072	$ 1,739	1,516,806	65,199	(860,479)	(3,193)	520
Beginning balance (in shares) at Jun. 30, 2024			173,942
Beginning balance at Jun. 30, 2024	732,761	732,260	$ 1,739	1,516,806	68,373	(856,026)	1,368	501
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(3,155)	(3,174)			(3,174)			19
Other comprehensive (loss) income	(4,561)	(4,561)					(4,561)
Cash distributions declared	$ (4,453)	(4,453)				(4,453)
Ending balance (in shares) at Sep. 30, 2024	175,274		173,942
Ending balance at Sep. 30, 2024	$ 720,592	$ 720,072	$ 1,739	$ 1,516,806	$ 65,199	$ (860,479)	$ (3,193)	$ 520

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Cash distributions declared (in dollars per share)	$ 0.0256	$ 0.0256	$ 0.0768	$ 0.0768

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net cash flows provided by operating activities	$ 30,965	$ 24,616
Investing activities:
Capital expenditures	(9,165)	(10,463)
Purchase of held-to-maturity securities	0	(4,880)
Proceeds from maturity of short-term securities	0	15,000
Net cash flows used in investing activities	(9,165)	(343)
Financing activities:
Distributions to stockholders	(13,359)	(13,360)
Repayments on credit facilities	(10,000)	0
Purchase of interest rate cap	(100)	(3,211)
Principal payments on mortgages and other notes payable	(654)	(25,067)
Other financing activities	(14)	(512)
Net cash flows used in financing activities	(24,127)	(42,150)
Net decrease in cash and restricted cash	(2,327)	(17,877)
Cash and restricted cash at beginning of period	55,888	73,574
Cash and restricted cash at end of period	$ 53,561	$ 55,697

Organization	9 Months Ended
Organization	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization CNL Healthcare Properties, Inc. (the “Company”) is a Maryland corporation that elected to be taxed as a real estate investment trust (“REIT”) for United States (“U.S.”) federal income tax purposes. The Company has been and intends to continue to be organized and operate in a manner that allows it to remain qualified as a REIT for U.S. federal income tax purposes. The Company conducts substantially all of its operations either directly or indirectly through: (1) an operating partnership, CHP Partners, LP (“Operating Partnership”), in which the Company is the sole limited partner and its wholly-owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned taxable REIT subsidiary (“TRS”), CHP TRS Holding, Inc.; (3) property owner and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures. The Company is externally managed and advised by CNL Healthcare Corp. (“Advisor”), which is an affiliate of CNL Financial Group, LLC (“Sponsor”). The Sponsor is an affiliate of CNL Financial Group, Inc. (“CNL”). The Advisor is responsible for managing the Company’s day-to-day operations, serving as a consultant in connection with policy decisions to be made by the board of directors, and for identifying, recommending and executing on possible strategic alternatives and dispositions on the Company’s behalf pursuant to an advisory agreement among the Company, the Operating Partnership and the Advisor (as amended, the “Advisory Agreement”). Substantially all of the Company’s operating, administrative and certain property management services are provided by affiliates of the Advisor. In addition, certain property management services are provided by third-party property managers. In 2017, the Company began evaluating possible strategic alternatives to provide liquidity to the Company’s stockholders. As part of executing under possible strategic alternatives, the Company’s board of directors committed to a plan to sell 70 properties, consisting of medical office buildings, post-acute care facilities, acute care hospitals and several skilled nursing facilities across the U.S. The Company completed the sale of the last of the 70 properties in 2022. As of September 30, 2024, the Company’s seniors housing portfolio was geographically diversified with properties in 26 states and consisted of interests in 70 properties, including 69 seniors housing communities and one vacant land parcel. The Company has primarily leased its seniors housing properties to wholly-owned TRS entities and engaged independent third-party managers under management agreements to operate the properties under the RIDEA structures; however, the Company has also leased some of its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). In addition, most of the Company’s investments have been wholly owned, although, it has, to a lesser extent, invested through partnerships with other entities where it was believed to be appropriate and beneficial.

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Consolidation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the nine months ended September 30, 2024 may not be indicative of the results that may be expected for the year ending December 31, 2024. Amounts as of December 31, 2023 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accompanying unaudited condensed consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest and the accounts of one variable interest entity (“VIE”) in which the Company is the primary beneficiary. All material intercompany accounts and transactions have been eliminated in consolidation. 2.Summary of Significant Accounting Policies (continued) Grant Income — In response to the coronavirus pandemic, the federal government and some states provided funds to providers of seniors housing communities under the CARES Act. These funds were deemed federal/state governmental grants and provided that the recipients attested to and complied with certain terms and conditions. Grant income is recognized upon receipt of the funds and when all the conditions of the grant have been met. During the nine months ended September 30, 2023, the Company recorded approximately $1.0 million as other income in the accompanying condensed consolidated statements of operations as all conditions of the grant had been met. The Company did not receive or recognize provider relief funds under the CARES Act during the quarter and nine months ended September 30, 2024. Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments (when such impairments exist), the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor through March 2017 pursuant to the Advisor expense support agreement (the “Expense Support Agreement”). Accordingly, actual results could differ from those estimates. Variable Interest Entities — As of September 30, 2024 and December 31, 2023, the Company had net assets in one subsidiary classified as a VIE. This subsidiary is a joint venture in which the Company’s equity interest consists of non-substantive protective voting rights. As of September 30, 2024, the Company determined it is the primary beneficiary and held a controlling financial interest in the subsidiary due to its power to direct the activities that most significantly impact the economic performance of this entity, as well as its obligation to absorb the losses and its right to receive benefits from this entity that could potentially be significant to this entity. As such, the transactions and accounts of this VIE are included in the accompanying condensed consolidated financial statements. The Company’s maximum exposure to loss as a result of its involvement with this VIE is limited to its net investment in this entity which totaled approximately $9.9 million as of September 30, 2024. The Company’s exposure is limited because of the non-recourse nature of the borrowings of this VIE. Recent Accounting Pronouncements — In November 2023, the FASB issued ASU 2023-07, “Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280)”, which requires incremental disclosures related to a public entity’s reportable segments. This ASU is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact adopting ASU 2023-07 will have on the Company's consolidated financial statements and disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures (Topic 740),” which requires entities to disclose in their rate reconciliation table additional categories of information about federal, state and foreign income taxes as well as additional information about reconciling items if certain quantitative thresholds are met. This ASU will require all entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has determined it will adopt this ASU on January 1, 2025, the adoption of which is not expected to have a material impact on the Company’s consolidated results of operations or cash flows.

Revenue

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue

The following table presents disaggregated revenue related to the Company’s resident fees and services during the quarter and nine months ended September 30, 2024 and 2023:


	Quarter Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	22.0	$	20.4	25.6	%	25.7	%
Assisted living	3,048	3,039	42.9		39.5		49.9		49.7
Memory care	923	932	16.8		15.5		19.6		19.5
Other revenues	—	—	4.2		4.1		4.9		5.1
	6,193	6,193	$	85.9	$	79.5	100.0	%	100.0	%

	Nine Months Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	64.9	$	60.0	25.7	%	25.5	%
Assisted living	3,048	3,039	125.3		117.1		49.7		49.9
Memory care	923	932	49.4		46.1		19.6		19.6
Other revenues	—	—	12.6		11.7		5.0		5.0
	6,193	6,193	$	252.2	$	234.9	100.0	%	100.0	%

Real Estate Assets, net

9 Months Ended

Sep. 30, 2024

Real Estate [Abstract]

Real Estate Assets, net

The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of September 30, 2024 and December 31, 2023 are as follows (in thousands):


	September 30, 2024		December 31, 2023
Land and land improvements	$	138,002	$	137,393
Building and building improvements	1,507,133		1,502,579
Furniture, fixtures and equipment	118,789		113,034
Less: accumulated depreciation	(511,463)		(473,869)
Real estate investment properties, net	$	1,252,461	$	1,279,137

Indebtedness

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Indebtedness


2024	$	20,314
2025	308
2026	553,542
2027	—
2028	—
Thereafter	—
	$	574,164

The following table provides the details of the fair market value and carrying value of the Company’s indebtedness as of September 30, 2024 and December 31, 2023 (in millions):


	September 30, 2024				December 31, 2023
	Fair Value		Carrying Value		Fair Value		Carrying Value
Mortgages and other notes payable, net	$	36.2	$	36.0	$	36.8	$	36.6
Credit facilities, net (1)	$	538.0	$	533.8	$	548.0	$	541.8

______________________________

FOOTNOTE:

(1)The carrying value of credit facilities, net includes unamortized debt issuance costs of approximately $4.2 million and $6.2 million as of September 30, 2024 and December 31, 2023, respectively.

Related Party Arrangements

9 Months Ended

Sep. 30, 2024

Related Party Arrangements


	Quarter Ended				Nine Months Ended
	September 30,				September 30,				Unpaid amounts as of (1)
	2024		2023		2024		2023		September 30, 2024		December 31, 2023
Reimbursable expenses:
Operating expenses (2)	$	619	$	687	$	2,082	$	2,081	$	177	$	180
	619		687		2,082		2,081		177		180



Financing coordination fees (3)	—		—		—		163		—		—
Asset management fees	3,337		3,476		10,011		10,427		—		1,112
	$	3,956	$	4,163	$	12,093	$	12,671	$	177	$	1,292

______________________________

FOOTNOTES:

(1)Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

The following summarizes the terms of the Company's interest rate caps and swaps and the corresponding asset (liability) as of September 30, 2024 and December 31, 2023 (in thousands):


Notional Amount(1)		Strike		Credit Spread(2)		Trade	Forward	Maturity Date	Fair Value Asset (Liability) as of
									September 30, 2024		December 31, 2023
Caps

$	8,000	3.50	%	2.60	%	6/29/2023	7/3/2023	1/1/2024	$	—	$	—
$	8,000	3.50	%	2.60	%	12/20/2023	1/2/2024	7/1/2024	$	—	$	63
$	8,000	3.00	%	2.60	%	6/28/2024	7/1/2024	1/2/2025	$	33	$	—
Swaps
$	267,000	4.40	%	2.35	%	12/7/2023	12/1/2023	12/1/2025	$	(2,193)	$	(1,678)
$	80,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(785)	$	(706)
$	20,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(197)	$	(177)

______________

FOOTNOTES:

(2)The all-in rates are equal to the sum of the Strike and Credit Spread.

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies From time to time, the Company may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, its business, including proceedings to enforce its contractual or statutory rights. While the Company cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, the Company does not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on its results of operations or financial condition. The Company’s Advisor has approximately 1.3 million contingently issuable Restricted Stock shares that were issued pursuant to the Expense Support Agreement. The Restricted Stock shares were treated as unissued for financial reporting purposes because the vesting criteria had not been met as of September 30, 2024. Refer to Note 6. “Related Party Arrangements” for information on distributions declared related to these Restricted Stock shares.

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the nine months ended September 30, 2024 may not be indicative of the results that may be expected for the year ending December 31, 2024. Amounts as of December 31, 2023 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accompanying unaudited condensed consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest and the accounts of one variable interest entity (“VIE”) in which the Company is the primary beneficiary.
Consolidation	All material intercompany accounts and transactions have been eliminated in consolidation.
Grant Income	In response to the coronavirus pandemic, the federal government and some states provided funds to providers of seniors housing communities under the CARES Act. These funds were deemed federal/state governmental grants and provided that the recipients attested to and complied with certain terms and conditions. Grant income is recognized upon receipt of the funds and when all the conditions of the grant have been met.
Use of Estimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments (when such impairments exist), the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor through March 2017 pursuant to the Advisor expense support agreement (the “Expense Support Agreement”). Accordingly, actual results could differ from those estimates.
Variable Interest Entities	As of September 30, 2024 and December 31, 2023, the Company had net assets in one subsidiary classified as a VIE. This subsidiary is a joint venture in which the Company’s equity interest consists of non-substantive protective voting rights. As of September 30, 2024, the Company determined it is the primary beneficiary and held a controlling financial interest in the subsidiary due to its power to direct the activities that most significantly impact the economic performance of this entity, as well as its obligation to absorb the losses and its right to receive benefits from this entity that could potentially be significant to this entity. As such, the transactions and accounts of this VIE are included in the accompanying condensed consolidated financial statements. The Company’s maximum exposure to loss as a result of its involvement with this VIE is limited to its net investment in this entity which totaled approximately $9.9 million as of September 30, 2024. The Company’s exposure is limited because of the non-recourse nature of the borrowings of this VIE.
Recent Accounting Pronouncements	In November 2023, the FASB issued ASU 2023-07, “Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280)”, which requires incremental disclosures related to a public entity’s reportable segments. This ASU is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact adopting ASU 2023-07 will have on the Company's consolidated financial statements and disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures (Topic 740),” which requires entities to disclose in their rate reconciliation table additional categories of information about federal, state and foreign income taxes as well as additional information about reconciling items if certain quantitative thresholds are met. This ASU will require all entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has determined it will adopt this ASU on January 1, 2025, the adoption of which is not expected to have a material impact on the Company’s consolidated results of operations or cash flows.

Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The following table presents disaggregated revenue related to the Company’s resident fees and services during the quarter and nine months ended September 30, 2024 and 2023:


	Quarter Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	22.0	$	20.4	25.6	%	25.7	%
Assisted living	3,048	3,039	42.9		39.5		49.9		49.7
Memory care	923	932	16.8		15.5		19.6		19.5
Other revenues	—	—	4.2		4.1		4.9		5.1
	6,193	6,193	$	85.9	$	79.5	100.0	%	100.0	%

	Nine Months Ended September 30,
	Number of Units		Revenues (in millions)				Percentage of Revenues
Resident fees and services:	2024	2023	2024		2023		2024		2023
Independent living	2,222	2,222	$	64.9	$	60.0	25.7	%	25.5	%
Assisted living	3,048	3,039	125.3		117.1		49.7		49.9
Memory care	923	932	49.4		46.1		19.6		19.6
Other revenues	—	—	12.6		11.7		5.0		5.0
	6,193	6,193	$	252.2	$	234.9	100.0	%	100.0	%

Real Estate Assets, net (Tables)

9 Months Ended

Sep. 30, 2024

Real Estate [Abstract]

Summary of Gross Carrying Amount and Accumulated Depreciation of Real Estate Assets

The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of September 30, 2024 and December 31, 2023 are as follows (in thousands):


	September 30, 2024		December 31, 2023
Land and land improvements	$	138,002	$	137,393
Building and building improvements	1,507,133		1,502,579
Furniture, fixtures and equipment	118,789		113,034
Less: accumulated depreciation	(511,463)		(473,869)
Real estate investment properties, net	$	1,252,461	$	1,279,137

Indebtedness (Tables)

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Summary of Future Principal Payments


2024	$	20,314
2025	308
2026	553,542
2027	—
2028	—
Thereafter	—
	$	574,164

Summary of Fair Market Value and Carrying Value of Indebtedness

The following table provides the details of the fair market value and carrying value of the Company’s indebtedness as of September 30, 2024 and December 31, 2023 (in millions):


	September 30, 2024				December 31, 2023
	Fair Value		Carrying Value		Fair Value		Carrying Value
Mortgages and other notes payable, net	$	36.2	$	36.0	$	36.8	$	36.6
Credit facilities, net (1)	$	538.0	$	533.8	$	548.0	$	541.8

______________________________

FOOTNOTE:

(1)The carrying value of credit facilities, net includes unamortized debt issuance costs of approximately $4.2 million and $6.2 million as of September 30, 2024 and December 31, 2023, respectively.

Related Party Arrangements (Tables)

9 Months Ended

Sep. 30, 2024

Summary of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties


	Quarter Ended				Nine Months Ended
	September 30,				September 30,				Unpaid amounts as of (1)
	2024		2023		2024		2023		September 30, 2024		December 31, 2023
Reimbursable expenses:
Operating expenses (2)	$	619	$	687	$	2,082	$	2,081	$	177	$	180
	619		687		2,082		2,081		177		180



Financing coordination fees (3)	—		—		—		163		—		—
Asset management fees	3,337		3,476		10,011		10,427		—		1,112
	$	3,956	$	4,163	$	12,093	$	12,671	$	177	$	1,292

______________________________

FOOTNOTES:

(1)Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Equity Method Investment's, Interest Rate Caps and Corresponding Asset (Liability) and Gross and Net Presentation of Amounts

The following summarizes the terms of the Company's interest rate caps and swaps and the corresponding asset (liability) as of September 30, 2024 and December 31, 2023 (in thousands):


Notional Amount(1)		Strike		Credit Spread(2)		Trade	Forward	Maturity Date	Fair Value Asset (Liability) as of
									September 30, 2024		December 31, 2023
Caps

$	8,000	3.50	%	2.60	%	6/29/2023	7/3/2023	1/1/2024	$	—	$	—
$	8,000	3.50	%	2.60	%	12/20/2023	1/2/2024	7/1/2024	$	—	$	63
$	8,000	3.00	%	2.60	%	6/28/2024	7/1/2024	1/2/2025	$	33	$	—
Swaps
$	267,000	4.40	%	2.35	%	12/7/2023	12/1/2023	12/1/2025	$	(2,193)	$	(1,678)
$	80,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(785)	$	(706)
$	20,000	4.54	%	2.35	%	12/8/2023	12/1/2023	12/1/2025	$	(197)	$	(177)

______________

FOOTNOTES:

(2)The all-in rates are equal to the sum of the Strike and Credit Spread.

Organization (Details)	9 Months Ended	12 Months Ended
Organization (Details)	Sep. 30, 2024 State land property	Dec. 31, 2022 property	Dec. 31, 2017 property
MOB/Healthcare Portfolio
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of properties			70
Number of properties sold		70
Investment Portfolio
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of properties	70
Number of states \| State	26
Number of seniors housing properties	69
Investment Portfolio \| Vacant Land Parcel
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of properties \| land	1

Summary of Significant Accounting Policies (Details)	3 Months Ended	9 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($) entity subsidiary	Sep. 30, 2023 USD ($)	Dec. 31, 2023 subsidiary
Summary Of Significant Accounting Policies [Line Items]
Number of variable interest entities \| entity		1
Grant income received	$ 0	$ 0	$ 1,000,000.0
Maximum exposure to loss VIEs limits	$ 9,900,000	$ 9,900,000
VIEs \| Joint Ventures Real Estate Under Development Entities
Summary Of Significant Accounting Policies [Line Items]
Number of subsidiaries \| subsidiary		1		1

Revenue (Details) $ in Thousands	3 Months Ended		9 Months Ended
Revenue (Details) $ in Thousands	Sep. 30, 2024 USD ($) facility	Sep. 30, 2023 USD ($) facility	Sep. 30, 2024 USD ($) facility	Sep. 30, 2023 USD ($) facility
Disaggregation Of Revenue [Line Items]
Number of Units \| facility	6,193	6,193	6,193	6,193
Revenues \| $	$ 85,877	$ 79,483	$ 252,223	$ 234,892
Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Disaggregation Of Revenue [Line Items]
Percentage of Revenues	100.00%	100.00%	100.00%	100.00%
Independent living
Disaggregation Of Revenue [Line Items]
Number of Units \| facility	2,222	2,222	2,222	2,222
Revenues \| $	$ 22,000	$ 20,400	$ 64,900	$ 60,000
Independent living \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Disaggregation Of Revenue [Line Items]
Percentage of Revenues	25.60%	25.70%	25.70%	25.50%
Assisted living
Disaggregation Of Revenue [Line Items]
Number of Units \| facility	3,048	3,039	3,048	3,039
Revenues \| $	$ 42,900	$ 39,500	$ 125,300	$ 117,100
Assisted living \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Disaggregation Of Revenue [Line Items]
Percentage of Revenues	49.90%	49.70%	49.70%	49.90%
Memory care
Disaggregation Of Revenue [Line Items]
Number of Units \| facility	923	932	923	932
Revenues \| $	$ 16,800	$ 15,500	$ 49,400	$ 46,100
Memory care \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Disaggregation Of Revenue [Line Items]
Percentage of Revenues	19.60%	19.50%	19.60%	19.60%
Other revenues
Disaggregation Of Revenue [Line Items]
Number of Units \| facility	0	0	0	0
Revenues \| $	$ 4,200	$ 4,100	$ 12,600	$ 11,700
Other revenues \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Disaggregation Of Revenue [Line Items]
Percentage of Revenues	4.90%	5.10%	5.00%	5.00%

Real Estate Assets, Net - Summary of Gross Carrying Amount and Accumulated Depreciation of Real Estate Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Real Estate [Abstract]
Land and land improvements	$ 138,002	$ 137,393
Building and building improvements	1,507,133	1,502,579
Furniture, fixtures and equipment	118,789	113,034
Less: accumulated depreciation	(511,463)	(473,869)
Real estate investment properties, net	$ 1,252,461	$ 1,279,137

Real Estate Assets, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Real Estate [Abstract]
Depreciation expense	$ 12.6	$ 12.5	$ 37.7	$ 37.6

Indebtedness - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended		9 Months Ended
Indebtedness - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Line of Credit Facility [Line Items]
Principal payments on mortgages and other notes payable			$ 654	$ 25,067
Repayments on credit facilities			10,000	0
Short-term interest rate cap			100	$ 3,211
Secured debt			$ 574,164
Maximum allowable distributions as a percentage of adjusted FFO			70.00%
Interest Rate Cap Maturing January 2025
Line of Credit Facility [Line Items]
Short-term interest rate cap	$ 100
Notional amounts of derivative contract	$ 8,000
Strike rate (as a percent)	3.00%
Revolving Credit Facility
Line of Credit Facility [Line Items]
Repayments on credit facilities		$ 10,000
Mortgages and other notes payable, net
Line of Credit Facility [Line Items]
Principal payments on mortgages and other notes payable			$ 700
Secured debt			36,000		$ 36,600
Secured Debt
Line of Credit Facility [Line Items]
Secured debt	$ 16,000
Fair value of cash flow hedge			$ 30

Indebtedness - Summary of Future Principal Payments (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
2024	$ 20,314
2025	308
2026	553,542
2027	0
2028	0
Thereafter	0
Total	$ 574,164

Indebtedness - Summary of Fair Market Value and Carrying Value of Indebtedness (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Carrying Value	$ 574,164
Credit facilities, net
Debt Instrument [Line Items]
Fair Value	538,000		$ 548,000
Carrying Value	533,800		541,800
Unamortized debt issuance costs	4,200		6,200
Mortgages and other notes payable, net
Debt Instrument [Line Items]
Fair Value	36,200		36,800
Carrying Value	$ 36,000		$ 36,600
Secured Debt
Debt Instrument [Line Items]
Carrying Value		$ 16,000

Related Party Arrangements - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Related Party Transaction [Line Items]
Cash distributions on restricted stock			$ 13,359	$ 13,360
Restricted Stock \| Related Party
Related Party Transaction [Line Items]
Cash distributions on restricted stock	$ 30	$ 100	$ 30	$ 100

Related Party Arrangements - Summary of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($) property	Dec. 31, 2023 USD ($)
Line of Credit Facility [Line Items]
Financing coordination fees	$ 0	$ 0	$ 0	$ 163,000
Total reimbursable expenses, net	3,956,000	4,163,000	12,093,000	12,671,000
Asset management fees
Line of Credit Facility [Line Items]
Asset management fees	3,337,000	3,476,000	10,011,000	10,427,000
Related Party
Line of Credit Facility [Line Items]
Operating expenses	619,000	687,000	2,082,000	2,081,000
Total reimbursable expenses	619,000	687,000	2,082,000	2,081,000
Financing coordination fees	0	0	0	$ 163,000
Other liabilities/Due to related parties	177,000		177,000		$ 1,292,000
Number of properties \| property				5
Related Party \| Reimbursable Expenses
Line of Credit Facility [Line Items]
Other liabilities/Due to related parties	177,000		177,000		180,000
Related Party \| Reimbursable Operating Expenses
Line of Credit Facility [Line Items]
Other liabilities/Due to related parties	177,000		177,000		180,000
Related Party \| Financing Coordination Fee
Line of Credit Facility [Line Items]
Other liabilities/Due to related parties	0		0		0
Related Party \| Asset Management Fee
Line of Credit Facility [Line Items]
Other liabilities/Due to related parties	0		0		$ 1,112,000
Related Party \| Asset management fees
Line of Credit Facility [Line Items]
Asset management fees	$ 3,337,000	$ 3,476,000	$ 10,011,000	$ 10,427,000

Derivative Financial Instruments - Summary of Equity Method Investment's, Interest Rate Caps and Corresponding Asset (Liability) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Interest Rate Cap One
Derivative [Line Items]
Notional Amount	$ 8,000
Strike	3.50%
Credit Spread	2.60%
Trade	Jun. 29, 2023
Forward	Jul. 03, 2023
Maturity Date	Jan. 01, 2024
Fair value asset (liability)	$ 0	$ 0
Interest Rate Cap Two
Derivative [Line Items]
Notional Amount	$ 8,000
Strike	3.50%
Credit Spread	2.60%
Trade	Dec. 20, 2023
Forward	Jan. 02, 2024
Maturity Date	Jul. 01, 2024
Fair value asset (liability)	$ 0	63
Interest Rate Cap Three
Derivative [Line Items]
Notional Amount	$ 8,000
Strike	3.00%
Credit Spread	2.60%
Trade	Jun. 28, 2024
Forward	Jul. 01, 2024
Maturity Date	Jan. 02, 2025
Fair value asset (liability)	$ 33	0
Interest Rate Swap One
Derivative [Line Items]
Notional Amount	$ 267,000
Strike	4.40%
Credit Spread	2.35%
Trade	Dec. 07, 2023
Forward	Dec. 01, 2023
Maturity Date	Dec. 01, 2025
Fair value asset (liability)	$ (2,193)	(1,678)
Interest Rate Swap Two
Derivative [Line Items]
Notional Amount	$ 80,000
Strike	4.54%
Credit Spread	2.35%
Trade	Dec. 08, 2023
Forward	Dec. 01, 2023
Maturity Date	Dec. 01, 2025
Fair value asset (liability)	$ (785)	(706)
Interest Rate Swap Three
Derivative [Line Items]
Notional Amount	$ 20,000
Strike	4.54%
Credit Spread	2.35%
Trade	Dec. 08, 2023
Forward	Dec. 01, 2023
Maturity Date	Dec. 01, 2025
Fair value asset (liability)	$ (197)	$ (177)

Derivative Financial Instruments - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest rate cap agreement
Derivative [Line Items]
Reclassified from accumulated other comprehensive income (loss) into earnings	$ 50,000.00	$ 1,000,000	$ 100,000	$ 3,300,000
Reclassified from accumulated other comprehensive income into earnings in the next 12 months net	30,000.00		30,000.00
Interest Rate Swap
Derivative [Line Items]
Reclassified from accumulated other comprehensive income (loss) into earnings	0		0
Reclassified from accumulated other comprehensive income into earnings in the next 12 months net	$ 0		$ 0
Fair value asset (liability)		$ 0		$ 0

Commitments and Contingencies (Details) shares in Millions	9 Months Ended
Commitments and Contingencies (Details) shares in Millions	Sep. 30, 2024 shares
Advisor Expense Support Agreement \| Restricted Stock
Commitments And Contingencies [Line Items]
Contingently issuable restricted stock shares	1.3

CNL Healthcare Properties (PK) (USOTC:CHTH)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more CNL Healthcare Properties (PK) Charts.

CNL Healthcare Properties (PK) (USOTC:CHTH)
Historical Stock Chart
From Nov 2023 to Nov 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CHTH CNL Healthcare Properties Inc (PK)

Latest CHTH Messages

Loading Messages....

CNL Healthcare Properties Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CHTH CNL Healthcare Properties Inc (PK)

Latest CHTH Messages

Loading Messages....

CNL Healthcare Properties Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%